US20110151534A1 - Industrial production of organic compounds using recombinant organisms expressing methyl halide transferase - Google Patents

Industrial production of organic compounds using recombinant organisms expressing methyl halide transferase Download PDF

Info

Publication number
US20110151534A1
US20110151534A1 US12/745,538 US74553808A US2011151534A1 US 20110151534 A1 US20110151534 A1 US 20110151534A1 US 74553808 A US74553808 A US 74553808A US 2011151534 A1 US2011151534 A1 US 2011151534A1
Authority
US
United States
Prior art keywords
halide
mht
methyl halide
methyl
yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/745,538
Other languages
English (en)
Inventor
Christopher A. Voigt
Daniel V. Santi
Travis S. Bayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/745,538 priority Critical patent/US20110151534A1/en
Assigned to THE REGENTS OF THE UNIVERSITY OF CALIFORNIA reassignment THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAYER, TRAVIS S., VOIGT, CHRISTOPHER
Publication of US20110151534A1 publication Critical patent/US20110151534A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Definitions

  • the invention relates to production of biofuels and other methyl halide derivatives by cultivation of genetically modified organisms expressing methyl halide transferase.
  • Methyl halides are reactive one-carbon compounds from which a wide variety of commercially important organic products can be produced.
  • Industrial production of methyl halides has been carried out using chemical methods that often consume high amounts of energy, and involve conditions of high temperature and pressure.
  • a common method for industrial production of methyl halides involves reaction of methanol with gaseous hydrogen chloride in the presence of an aluminum oxide catalyst at elevated temperature and under a pressure of at least 1 bar. See, e.g., McKetta, J., C HEMICAL P ROCESSING H ANDBOOK, 1993.
  • methyl halide transferases that combine a chlorine, bromine or iodine ion with a methyl group of the metabolite S-adenosylmethionine (“AdoMet” or “SAM”) to form the methyl halide and S-adenosyl homocysteine.
  • the invention includes a process comprising combining (i) an organism comprising a S-adenosylmethionine (SAM)-dependent methyl halide transferase (MHT), (ii) a halide selected from the group comprising chlorine, bromine and iodine; and (iii) a carbon source in a cultivation medium, under conditions in which methyl halide is produced.
  • SAM S-adenosylmethionine
  • MHT methyl halide transferase
  • a halide selected from the group comprising chlorine, bromine and iodine and
  • a carbon source in a cultivation medium
  • the methyl halide can optionally be collected.
  • the methyl halide can be converted into a non-halogenated organic molecule or a mixture of non-halogenated organic molecules, which can optionally be collected.
  • the process can be carried out on a commercial scale, for example in a reactor.
  • the invention also provides a genetically modified algae, fungus or bacteria, comprising a heterologous S-adenosylmethionine (SAM)-dependent methyl halide transferase gene, that is genetically modified to increase flux through a S-adenosyl-methionine (SAM) biosynthetic pathway; and/or genetically modified to increase the intracellular halide concentration.
  • SAM S-adenosylmethionine
  • SAM S-adenosylmethionine
  • Useful organisms include algae, yeast and bacteria.
  • the recombinant organism can be a gram negative bacterium, e.g., E. coli, Salmonella, Rhodobacter, Synechtocystis , or Erwinia .
  • Other gram negative bacteria include members from the Methylococcaceae and Methylocystaceae families; Thermotoga hypogea, Thermotoga naphthophila, Thermotoga subterranean, Petrotoga halophila, Petrotoga mexicana, Petrotoga miotherma , and Petrotoga mobilis .
  • the recombinant organism can be a gram positive bacterium, e.g., B.
  • the recombinant organism can be a fungus such as Saccharomyces cerevisae, Pichia pastoris, Hansenula polymorpha, Kluyveromyces lactis, Yarrowia lipolytica, Scizosacchromyces pombe or Trichoderma reesei or other yeast species of genus Saccharomyces, Pichia, Hansenula, Kluyveromyces, Yarrowia, Trichoderma or Scizosacchromyces .
  • the recombinant organism can also be a eukaryote such as an algae.
  • Example of algae include Chlamydomonas.
  • the organism optionally comprises a gene encoding a heterologous MHT.
  • the MHT can be a naturally-occurring MHT or a synthetic MHT. If so desired, the expression of the heterologous MHT can be under the control of an inducible promoter.
  • MHTs include, for example and not limitation, MHTs from Batis maritima, Burkholderia phymatum, Synechococcus elongatus, Brassica rapa, Brassica oleracea, Arabidopsis thaliana, Arabidopsis thaliana, Leptospirillum, Cryptococcus neoformans, Oryza sativa, Ostreococcus tauri, Dechloromonas aromatica, Coprinopsis cinerea, Robiginitalea bofirmata, Maricaulis maris, Flavobacteria bacterium, Vitis vinifera or halorhodospira halophile .
  • MHTs include (but are not limited to) MHTs from B. xenovorans, B. rapa chinensis, B. pseudomallei, B. thailandensis , Marine bacterium HTCC2080, and R. picketti . Also see discussion below and FIG. 10A .
  • the organism can be genetically modified to increase flux through a S-adenosyl-methionine (SAM) biosynthetic pathway.
  • SAM S-adenosyl-methionine
  • the flux through the SAM biosynthetic pathway can be increased by expression or overexpression of a SAM synthetase.
  • the SAM synthetase can be E. coli metK, Rickettsia metK, S. cerevisae sam1p, or S. cerevisae sam2p.
  • the SAM synthetase optionally has at least 80% amino acid identity with E. Coli metK.
  • the flux through the SAM biosynthetic pathway can be increased by abolishing, inactivating or decreasing the expression and/or activity of at least one gene.
  • the gene can be involved in a SAM utilization pathway, e.g., coproporphyrinogen III oxidase, S-adenosylmethionine decarboxylase, cystathionine beta-synthetase, ribulose 5-phosphate 3-epimerase, glucose-6-phosphate dehydrogenase, L-alanine transaminase, 3′,5 -bisphosphate nucleotidase, glycine hydroxymethyltransferase, or glycine hydroxymethyltransferase.
  • a SAM utilization pathway e.g., coproporphyrinogen III oxidase, S-adenosylmethionine decarboxylase, cystathionine beta-synthetase, ribulose 5-phosphat
  • the flux through the SAM biosynthetic pathway can also be increased by increasing flux through a methionine biosynthetic pathway.
  • the flux through the methionine biosynthetic pathway can be increased by expression or overexpression of the E. coli metL, metA, metB, metC, metE, and/or metH genes.
  • a gene encoding a repressor of methionine biosynthesis e.g., E. coli metJ, can be inactivated.
  • the flux can be increased by expressing a SAM transporter protein such as the Sam5p yeast mitochondrial gene.
  • methyl halide production can be increased by expressing a gene that increases intracellular concentration and/or availability of ATP, and/or by increasing the intracellular halide concentration, for example through the overexpression of a halide transporter protein gene.
  • the halide transporter can be E. coli clc transporter or a gene that shares at least 80% amino acid sequence identity with the E. coli clc transporter.
  • the halide for use in the invention can be provided as a halide salt, e.g., sodium chloride, sodium bromide, and sodium iodide.
  • the halide can be present in the cultivation medium at a concentration of 0.05 to 0.3 M.
  • the cultivation medium optionally comprises methionine.
  • the methyl halide produced can be methyl chloride, methyl bromide, and/or methyl iodide.
  • the conversion of methyl halides into other products can be a result of catalytic condensation.
  • Useful catalysts include a zeolite catalyst, for example ZSM-5 or aluminum bromide (AlBr 3 ).
  • the catalytic condensation step results in the production of a halide which can be recycled back to the cultivation medium.
  • the methods of the invention can be used to produce a composition comprising an alkane, e.g., ethane, propane, butane, pentane, hexane, heptane, octane, or a mixture thereof.
  • alkane e.g., ethane, propane, butane, pentane, hexane, heptane, octane, or a mixture thereof.
  • Other organic molecules that can be produced include, without limitation, olefins, alcohols, ethers and/or aldehydes.
  • the organism can be genetically modified at multiple (e.g., 2, 3, 4, 5, or 6) loci.
  • the effect of each modification individually can be to increase the production of methyl halide.
  • the invention provides a method including the steps of combining
  • a recombinant yeast comprising a heterologous gene encoding S-denosylmethionine (SAM)-dependent methyl halide transferase (MHT), ii) a halide selected from the group comprising chlorine, bromine and iodine; and iii) a carbon source; in a cultivation medium under conditions in which methyl halide is produced.
  • the method may further include the step of converting the methyl halide into a non-halogenated organic molecule or a mixture of non-halogenated organic molecules.
  • the yeast is from a genus selected from Saccharomyces, Pichia, Hansenula, Kluyveromyces, Yarrowia, Trichoderma and Scizosacchromyces .
  • the yeast may be Saccharomyces cerevisiae, Pichia pastoris, Hansenula polymorpha, Kluyveromyces lactis, Yarrowia lipolytica, Trichoderma reesei , or Scizosacchromyces pombe .
  • the MHT is from Batis maritima .
  • the carbon source is acetate and/or ethanol produced by a metabolism of cellulose by a cellulolytic microorganism.
  • the cellulolytic microorganism may be a bacterium, such as Actinotalea fermentans .
  • the cellulose is microcrystalline cellulose.
  • the cellulose is a chopped or pulverized feedstock (e.g., pulverized switchgrass, bagasse, elephant grass, corn stover, and poplar).
  • the invention provides a co-culture system comprising yeast and cellulosic bacteria, wherein the yeast express at least one heterologous protein.
  • the co-culture system may contain cellulose.
  • the co-culture system contains one species of yeast and one species of bacteria.
  • the yeast can be from a genus selected from the group consisting of Saccharomyces, Pichia, Hansenula, Kluyveromyces, Yarrowia, Trichoderma and Scizosacchromyces , for example S. cerevisiae.
  • the yeast and bacterium of the co-culture have a symbiotic relationship in culture.
  • the bacterium is Actinotalea fermentans.
  • the invention provides a stable in vitro co-culture of two microorganisms adapted to aerobically grow together while maintaining a relatively constant ratio of species populations such that neither microorganism overtakes the other.
  • the co-culture includes (i) a first microorganism component which metabolizes cellulose and produces one or more metabolic products; (ii) a second microorganism component which is recombinantly modified to express a heterologous protein, and which is metabolically incapable of degrading cellulose, where the second microorganism uses the metabolic products of the first microorganism as a carbon source.
  • the first microorganism is a cellulosic bacteria and the second microorganism is a yeast.
  • the yeast expresses a heterologous methyl halide transferase.
  • the yeast is S. cerevisiae and the bacterium is Actinotalea fermentans.
  • the heterologous gene encodes a fusion protein comprising a MHT sequence and a targeting peptide sequence that targets the MHT sequence to the yeast vacuole.
  • the targeting peptide sequence can be the N-terminal peptide domain from carboxypeptidase Y.
  • the invention provides a method for production of methyhalide comprising culturing a first microorganism which metabolizes cellulose and produces one or more metabolic products together with a second microorganism which does not metabolize cellulose and which is recombinantly modified to express a heterologous methyl halide transferase protein in a medium containing cellulose and a halide, under conditions in which methyl halide is produced.
  • the halide is chlorine, bromine and iodine.
  • the invention provides a recombinant yeast cell comprising a heterologous gene encoding S-adenosylmethionine (SAM)-dependent methyl halide transferase (MHT).
  • SAM S-adenosylmethionine
  • MHT is from Batis maritima, Burkholderia phymatum, Synechococcus elongatus, Brassica rapa, Brassica oleracea, Arabidopsis thaliana, Arabidopsis thaliana, Leptospirillum, Cryptococcus neoformans, Oryza sativa, Ostreococcus tauri, Dechloromonas aromatica, Coprinopsis cinerea, Robiginitalea bofirmata, Maricaulis maris, Flavobacteria bacterium, Vitis vinifera or halorhodospira halophila .
  • the MHT is from B. xenovorans, B. rapa chinensis, B. pseudomallei, B. thailandensis , Marine bacterium FITCC2080, or R. picketti
  • the recombinant yeast cell is selected from Saccharomyces cerevisiae, Pichia pastoris, Hansenula polymorpha, Kluyveromyces lactis, Yarrowia lipolytica, Trichoderma reesei , and Scizosacchromyces pombe .
  • the recombinant yeast cell can be a Saccharomyces cerevisiae cell expressing a Batis maritima methyl halide transferase protein.
  • the MHT is expressed in the yeast cell as a fusion protein comprising a targeting peptide sequence that targets proteins to the yeast vacuole.
  • the targeting peptide sequence is the N-terminal peptide domain from carboxypeptidase Y.
  • a co-culture system comprising a culture medium a cellulosic bacterium component, where the bacteria metabolize cellulose and produce one or more metabolic products, and a yeast component, where the yeast uses at least one metabolic product of the bacteria as a carbon source.
  • the bacteria-yeast co-culture comprises Actinotalea fermentans bacteria which metabolize cellulose and produce one or more metabolic products, and S. cerevisiae yeast, where the yeast uses at least one metabolic product produced by the bacteria as a carbon source.
  • the culture medium may contain cellulose.
  • the yeast is metabolically incapable of degrading cellulose.
  • the metabolic product(s) is the sole or primary carbon and energy source for the yeast.
  • the yeast is recombinantly modified to express a heterologous protein or over-express an endogenous protein. In some embodiments the yeast is a recombinantly modified to knock out expression of an endogenous protein. In some embodiments the bacteria and yeast grow together while maintaining a relatively constant ratio of species populations such that neither microorganism overtakes the other.
  • the co-culture system may be maintained under substantially aerobic conditions or under substantially anaerobic conditions.
  • the yeast is from a genus selected from Saccharomyces, Pichia, Hansenula, Kluyveromyces, Yarrowia, Trichoderma and Scizosacchromyces .
  • the yeast is S. cerevisiae .
  • the bacteria is a Actinotalea or cellulomonas species.
  • the bacterium is Actinotalea fermentans .
  • the yeast is S. cerevisiae and the bacterium is Actinotalea fermentans .
  • the co-culture comprises only one species of yeast and only one species of bacteria.
  • the yeast and bacterium have a symbiotic relationship in culture.
  • the carbon source produced by the bacteria is molecule comprising 1-6 carbon atoms, such as, for example, ethanol, acetate, lactate, succinate, citrate, formate or malate.
  • the yeast expresses a heterologous protein.
  • the heterologous protein may be a mammalian protein such as, for example a human protein used for treatment of patients.
  • the heterologous protein is an enzyme, such as an enzyme that catalyzes a step in a synthetic pathway in the yeast.
  • the heterologous protein is a methyl halide transferase.
  • the yeast is genetically engineered to produce a commercially valuable small molecule compound.
  • the yeast is a naturally occurring or cultivated strain that is not recombinantly modified.
  • a yeast culture method comprising culturing cellulosic bacteria and yeast together in a culture medium in the presence of cellulose or a cellulose-source, under conditions in which (i) the bacteria metabolize cellulose and produce one or more metabolic products, and, (ii) the yeast component uses at least one metabolic product of the bacteria as a carbon source.
  • the culture medium is a liquid.
  • the cellulose is microcrystalline cellulose.
  • the cellulose-source is biomass, such as, without limitation, switchgrass, bagasse, elephant grass, corn stover, poplar (each of which may be pulverized) and mixtures of these and other biomass materials.
  • the culture is maintained under aerobic conditions. In some embodiments the culture is maintained under anaerobic conditions. In some embodiments the yeast and bacterium have a symbiotic relationship in culture. In some embodiments the yeast is metabolically incapable of degrading cellulose. In some embodiments the carbon source produced by the bacteria is molecule comprising 1-6 carbon atoms, such as, for example, ethanol, acetate, lactate, succinate, citrate, formate or malate.
  • the yeast in the co-culture is from a genus selected from Saccharomyces, Pichia, Hansenula, Kluyveromyces, Yarrowia, Trichoderma and Scizosacchromyces .
  • the yeast is S. cerevisiae .
  • the bacteria is a Actinotalea or Cellulomonas species.
  • the bacterium is Actinotalea fermentans .
  • the yeast is S. cerevisiae and the bacterium is Actinotalea fermentans .
  • the co-culture comprises only one species of yeast and only one species of bacteria.
  • the yeast and bacterium have a symbiotic relationship in culture.
  • the yeast is recombinantly modified to express a heterologous protein.
  • the heterologous protein may be a mammalian protein such as, for example a human protein used for treatment of patients.
  • the heterologous protein is an enzyme.
  • the heterologous protein is a methyl halide transferase.
  • the yeast is genetically engineered to produce a commercially valuable small molecule compound.
  • the yeast is a naturally occurring or cultivated strain that is not recombinantly modified.
  • the yeast is a recombinantly modified to knock out expression of an endogenous protein. In other embodiments the yeast is a naturally occurring or cultivated strain that is not recombinantly modified.
  • the method includes the step of recovering a product from the culture medium which product is produced by the yeast.
  • products that may be recovered include, but is not limited to, a recombinant protein expressed by the yeast, a small molecule synthesized by the yeast cell, a drug, food product, amino acid, cofactor, hormone, protein, vitamin, lipid, alkane, aromatic, olefin, alcohol, or biofuel intermediate.
  • the product is a methyl halide.
  • synthesis of the product requires expression of a heterologous protein in the yeast.
  • the synthesis requires expression of an endogenous protein that is overexpressed in the yeast or deletion of one or more endogenous genes of the yeast.
  • the invention provides a method for production of methyhalide comprising culturing a cellulosic bacteria which metabolizes cellulose and produces one or more metabolic products together with a yeast which does not metabolize cellulose and which is recombinantly modified to express a heterologous methyl halide transferase protein in a medium containing a cellulose source and a halide, under conditions in which methyl halide is produced.
  • the halide may be chlorine, bromine and iodine.
  • the invention provides a method comprising combining i) a recombinant yeast comprising a heterologous gene encoding S-adenosylmethionine (SAM)-dependent methyl halide transferase (MHT), ii) a halide selected from the group comprising chlorine, bromine and iodine; and iii) a cellulolytic bacteria that produces a carbon source by metabolism of cellulose; in a cultivation medium under conditions in which methyl halide is produced.
  • the carbon source is a molecule comprising 1-6 carbon atoms such as ethanol, acetate, lactate, succinate, formate, citrate, or malate.
  • the method includes recovering methyl halide from the culture medium and converting the methyl halide into a non-halogenated organic molecule or a mixture of non-halogenated organic molecules.
  • the yeast is S. cerevisiae or another yeast described hereinbelow.
  • the bacteria is Actinotalea fermentans or another cellulosic bacteria described hereinbelow.
  • the MHT is from Batis maritima or is another MHT described hereinbelow.
  • the yeast is S. cerevisiae
  • the bacteria is Actinotalea fermentans and the MHT is from Batis maritima.
  • FIG. 1 Methyl halide production by bacteria containing a recombinant methyl halide transferase (MHT) gene expressed from an IPTG-inducible promoter.
  • MHT methyl halide transferase
  • FIG. 2 Time-course of methyl halide production from bacteria containing a recombinant MHT gene expressed from an IPTG-inducible promoter, after addition of IPTG to the medium.
  • FIG. 3 Effect of bacterial growth phase on methyl halide production.
  • FIG. 4 Effect of halide salt concentration in the cultivation medium on methyl halide production.
  • FIG. 5 Effect of different halides on methyl halide production.
  • FIG. 6 Methyl halide production from bacteria overexpressing genes other than MHTs, e.g., metK.
  • FIG. 7 Methyl halide production achieved by bacteria expressing various heterologous MHTs from various organisms.
  • FIG. 8 A schematic of a bioreactor system for production of organic compounds.
  • FIG. 9A-C CH 3 I production from cellulosic feedstocks using a microbial co-culture.
  • FIG. 9A diagram of co-culture.
  • A. fermentans ferments cellulosic feedstocks to acetate and ethanol, which S. cerevisiae can respire as a carbon (and energy) source.
  • FIG. 9B left panel: growth of yeast in co-culture. Yeast were inoculated on carboxymethylcellulose (CMC) as the sole carbon sources with and without A. fermentans . Growth was measured as colony forming units.
  • FIG. 9B right panel: Growth of bacteria in co-culture.
  • FIG. 9C CH 3 I production from cellulosic feedstocks.
  • Co-cultures were seeded at low density and grown for 36 hours with the indicated feedstock (20 g/L) as the sole carbon source.
  • Sodium iodide was added and CH 3 I production was measured by GC-MS as before.
  • CH 3 I yields are reported in grams per liter per day, normalized by CFUs per mL of culture. Yields are shown for the A. fermentans - S. cerevisiae co-culture on acetate, CMC, switchgrass, corn stover, and poplar. Cultures grown without A. fermentans showed no methyl iodide activity.
  • FIG. 10A-B Screening the MHT library for methyl halide activity.
  • FIG. 10A methyl halide activity for MHT library in E. coli . Organisms that MHT genes are from are shown at left. Bacteria are shown in red font, plants are in green, fungi are blue, and archae are in purple. Production of CH 3 I, CH 3 Br, and CH 3 Clare shown. Genes are rank ordered by CH 3 I activity.
  • FIG. 10B assay of methyl halide activity for a subset of MHT library. Measurements were performed in triplicate and standard deviations are shown.
  • FIG. 11A-D Methyl iodide production in recombinant S. cerevisiae .
  • FIG. 11A CH 3 I production pathway.
  • the B. maritima MHT is expressed with a N-terminal vacuole targeting tag.
  • the ATP-dependent MHT methylates iodide ions using SAM as a methyl donor.
  • FIG. 11B CH 3 I measured in culture headspace over time. Activity on glucose-grown cells is shown.
  • FIG. 11C CH 3 I yields in grams per liter of culture per day. Values for the culturable red algae E. muricata are taken from the literature. Yields from B. maritima MHT-expressing E. coli and S.
  • FIG. 11D CH 3 I toxicity in yeast. Exponential phase cultures were diluted to an OD 600 of 0.05 and commercially available CH 3 I was added. OD 600 was measured at 24 hours of growth. The W303a lab strain is shown in filled boxes, the DNA methylation-sensitive RAD50 ⁇ mutant is shown in open boxes.
  • FIG. 12 Methyl iodide production improvement by targeting the B. maritima MHT to the yeast vacuole using a N-terminus fused CPY signal. Methyl iodide counts per hour are shown for each culture.
  • the vacuole targeted (CPY-MHT) and cytoplasmic MHT were expressed in the W303 strain and in a W303 strain harboring a VPS33 deletion, which abolishes vacuole formation.
  • Methyl halides can be converted to commodity chemicals and liquid fuels—including gasoline—using zeolite catalysts prevalent in the petrochemical industry.
  • the methyl halide transferase (MHT) enzyme transfers the methyl group from the ubiquitous metabolite S-adenoyl methionine (SAM) to a halide ion in an ATP-dependent manner.
  • SAM ubiquitous metabolite S-adenoyl methionine
  • the library was screened in Escherichia coli to identify the rates of CH 3 Cl, CH 3 Br, and CH 3 I production, with 56% of the library active on chloride, 85% on bromide, and 69% on iodide.
  • Expression of the highest activity MHT and subsequent engineering in Saccharomyces cerevisiae resulted in product yields of 4.5 g/L-day from glucose and sucrose, four orders of magnitude over culturable naturally occurring sources.
  • Using a symbiotic co-culture of the engineered yeast and the cellulolytic bacterium Actinotalea fermentans we were able to achieve methyl halide production from unprocessed switchgrass ( Panicum virgatum ), corn stover, and poplar.
  • Methyl halides produced from various biorenewable resources can to be used as 1-carbon precursors for the production of alkanes, aromatics, olefins, and alcohols in the chemical industry.
  • the invention provides methods for production of commodity chemical and fuels.
  • the invention provides methods for production of biofuels and other commercially valuable organic products.
  • recombinant bacteria, fungi or plant cells expressing a methyl halide transferase enzyme (MHT) are cultivated in the presence of a carbon source (e.g., agricultural or waste biomass, cultivation media, petroleum, natural gas application methane) under conditions in which methyl halide gas is produced.
  • a carbon source e.g., agricultural or waste biomass, cultivation media, petroleum, natural gas application methane
  • the MHT is heterologous.
  • the methyl halide is converted to non-halogenated organic compounds such as long-chain alkanes, olefins, alcohols, ethers, and aldehydes.
  • the organic compounds are suitable for use as biofuel.
  • methyl halide Conversion of methyl halide to other organic molecules can be achieved by any means and is not limited to a specific mechanism.
  • the MHT-expressing organism also expresses enzymes (endogenous or heterologous) that convert the methyl halide to another organic molecule, such as methanol.
  • the MHT-expressing organism releases methyl halide which is then converted by a different organism (natural or recombinant) to another organic molecule.
  • methyl halide is collected and converted by well-known chemical synthetic methods (e.g., catalytic condensation). Following conversion of the methyl halide into a non-halogenated organic molecule or a mixture of non-halogenated organic molecules, the non-halogenated organic molecule(s) may be collected and/or packaged for subsequent use.
  • the invention also includes organisms expressing a heterologous methyl halide transferase enzyme and having at least one other genetic modification that causes the organism to produce more methyl halide than an organism lacking the at least one other genetic modification.
  • An increase in yield of methyl halide in a MHT-expressing cell can be facilitated in various ways, for example by engineered SAM overproduction, increase in concentration and/or availability of ATP, expression of halide ion importers.
  • Manipulation of genes in various metabolic pathways allows creation of organisms able to efficiently convert the carbon from cellulose, sugar, waste materials, or CO 2 to methyl halide gas.
  • the invention also provides co-culture systems in which a cellulolytic bacterium and a yeast cell expressing a heterologous protein are cultured together.
  • the bacterium metabolizes cellulose to produce a product that serves as a carbon source for the yeast.
  • accumulation of the product in culture medium is toxic to the bacterial. Consumption of the product by the yeast cells serves to remove the product, so that the bacteria and yeast have a symbiotic relationship.
  • a variety of types of cells or organisms can be used in the practice of the invention, including cells that express an endogenous methyl-halide transferase (MHT), and cells modified to express an heterologous MHT.
  • MHT endogenous methyl-halide transferase
  • the organism is capable of producing about 1-1000 mg/L of methyl halide per day, often about 10-100 mg/L, such as about 20-60 mg/L, for example about 30-50 mg/L, or about 40 mg/L per day.
  • heterologous refers to a gene not normally in the cell genome, such as a gene from a different species or not found in nature, or a protein encoded by the heterologous gene.
  • a gene found in the wild-type cell genome, or protein normally expressed in the cell can be referred to as “endogenous.” Additional copies of an endogenous gene (under the control of a constitutive or inducible promoter) can be introduced into a host organisms to increase levels of an endogenous enzyme.
  • cells or organism should be suitable for commercial scale bioproduction, e.g., typically unicellular and/or fast-growing.
  • the term “cells” is used herein to encompass both MHT-expressing unicellular organisms, and MHT-expressing cells of multicellular organisms. Suitable cells may be eukaryotic or prokaryotic. Examples include bacterial, fungi, algae and higher plant cells.
  • Cells expressing endogenous MHT may be used.
  • the cell is usually selected or modified to express endogenous MHT at high levels and/or is selected or modified at other loci that affect methyl halide production, as is discussed below.
  • selection, with or without antecedent mutagenesis, may be used, recombinant techniques are usually preferred because they allow greater control over the final cell phenotype.
  • recombinant cells When recombinant cells are used, they may express a heterologous MHT, express a modified endogenous MHT, express an endogenous MHT at levels higher than wild-type cells, be modified at one or more loci other than the MHT gene (discussed below), or combinations of these modifications. Most preferably the cell expresses a heterologous MHT and is modified at least one other locus that affects methyl halide production.
  • the recombinant organism is not E. Coli .
  • the heterologous enzyme is not Batis MHT.
  • the recombinant organism is not E. coli containing a Batis MHT.
  • MHT-expressing cells are a source of MHT genes that can be transferred to a heterologous host, such as E. coli .
  • Organisms expressing MHTs include prokaryotes, e.g., bacteria or achaea. Examples of bacteria that can be used to produce MHT according to the invention include soil bacteria, and Proteobacteria, Methylobacterium chloromethanicum , and Hyphomicrobium chloromethanicum ).
  • the Proteobacteria phylum include genuses such as Pseudomonas and Burkholderia .
  • Burkholderia examples include Burkholderia xenovorans (previously named Pseudomonas cepacia then B. cepacia and B. fungorum ), known for the ability to degrade chlororganic pesticides and polychlorinated biphenyls (PCBs).
  • Burkholderia species include B. mallei, B. pseudomallei and B. cepacia .
  • Other prokaryotes such as Archaea can be used to produce MHT with or without modification.
  • Archaea examples include Sulfolobuses such as S. acidocaldarius, S. islandicus, S. metallicus, S. neozealandicus, S. shibatae, S. solfataricus , or S. sp. AM P12/99.
  • marine algae e.g., phytoplankton, giant kelp and seaweed
  • higher plants e.g., halophytic plants, Brassicaceae such as Brassica oleracea (TM1 or TM2), and Arabidopsis Thaliana (TM1 or TM2)
  • fungi e.g., yeast
  • Particular species include Batis maritima, Burkholderia phymatum STM815, Synechococcus elongatus PCC 6301, Brassica rapa subsp. chinensis; Leptospirillum sp. Group II UBA; Cryptococcus neoformans var.
  • cells used in the invention do not express an endogenous MHT, but are modified to express a heterologous MHT.
  • cells may be used that are modified to express a heterologous MHT and also express an endogenous MHT.
  • the use of cells expressing a heterologous MHT has several advantages. First, it is possible, using the methods described herein, to combine desirable properties of an organism (ease of culture, ability to metabolize a particular feedstocks, suitability for recombinant manipulation of other loci) with desirable properties of an MHT gene (e.g., high enzymatic activity).
  • Cells that can be genetically modified to express heterologous MHT include prokaryotes and eukaryotes such as plants, fungi and others.
  • prokaryotes include gram-negative bacteria such as E. Coli (e.g., MC1061, BL21 and DH10B), Salmonella (e.g., SL1344), Rhodobacter, Synechtocystis, Rickettsia , and Erwinia and gram-positive bacteria such as B. subtilis and Clostridium .
  • Exemplary plants include algae (e.g., Chlamydomonas, Chlorella and Prototheca ).
  • Exemplary fungi include Trichoderma reesei, Aspergillus and yeast (e.g., Saccharomyces cerevisae and Pichia ). Other cell types are disclosed herein and are known in the art. Other exemplary bacteria include Sulfobolus sulfaticaricus , and Caulobacter species such as Maricaulis maris.
  • An organism that efficiently metabolizes a particular carbon source can be selected to match an available feedstock.
  • organisms such as Erwinia, E. coli, Pichia, Clostridium , and Aspergillus Niger can be used.
  • E. coli and Saccharomyces are examples of organisms that can be used to metabolize starches and sugarcane.
  • photosynthetic organisms such as algae (e.g., Chlorella and Prototheca ) can metabolize carbon sources such as CO 2 .
  • a “methyl halide transferase (MHT)” is a protein that transfers a methyl group from S-adenosylmethionine to a halide.
  • MHT methyl halide transferase
  • Table 1 below lists some of the organisms known to have MHTs. Also see Figures, Tables 4 and 6 and Examples 8 and 9.
  • MHT genes can be cloned and introduced into a host organism under control of a promoter suitable for use in the host. Alternatively, genes encoding a desired MHT sequence can be synthesized, which allows codon usage in the gene to be optimized for the host.
  • the promoter can be inducible or constitutive.
  • the heterologous MHT gene can be integrated into the host chromosome (e.g., stable transfection) or can be maintained episomally.
  • Suitable MHTs are not limited to proteins encoded by naturally occurring genes.
  • techniques of directed evolution can be used to produce new or hybrid gene products with methyl transferase activity.
  • catalytically active fragments and variants of naturally occurring MHTs can be used.
  • MHTs such as enzymes designed in silico or produced by using art-known techniques for directed evolution including gene shuffling, family shuffling, staggered extension process (StEP), random chimeragenesis on transient templates (RACHITT), iterative truncation for the creation of hybrid enzymes (ITCHY), recombined extension on truncated templates (RETT), and the like
  • StEP staggered extension process
  • RACHITT random chimeragenesis on transient templates
  • ITCHY iterative truncation for the creation of hybrid enzymes
  • RTT recombined extension on truncated templates
  • Crameri et al. 1998, “DNA shuffling of a family of genes from diverse species accelerates directed evolution” Nature 391:288-91; Rubin-Pitel et al., 2006, “Recent advances in biocatalysis by directed enzyme evolution” Comb Chem High Throughput Screen 9:247-57; Johannes and Zhao, 2006, “Directed
  • MHT can effect the transfer of a methyl group from S-adenosylmethionine to a halide (i.e., chlorine, iodine and/or bromine) in the host organism.
  • MHT enzyme activity can be measured using various assays known in the art. Assays can measure activity of purified or partially purified protein. See, e.g., Ni and Hager, 1999, Proc. Natl. Acad. Sci. USA 96:3611-15 and Nagatoshi and Nakamura, 2007, Plant Biotechnology 24:503-506.
  • a protein can be expressed a cell that does otherwise express MHT and methyl halide production measured is described in the Examples, infra, and other art-know assays.
  • an expression vector with a sequence encoding the MHT protein is introduced into a bacterial (e.g., E. coli ) host cell and transformants selected. Clones are incubated in growth media in a tube or flask (e.g., LB media containing NaCl, NaI or NaBr and incubated at 37° C. for 4-22 hours with shaking. If the MHT encoding sequence is under control of an inducible promoter the inducing agent is included.
  • the tube or flask is sealed (e.g., with parafilm and aluminum foil cinched with a rubber band).
  • the level of MeX in the headspace gas is determined, e.g., by gas chromatography.
  • the invention includes the use of enzymatically active polypeptides with at least about 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95% or at least 99% identity with a known SAM-dependent methyhalide transferase (such as a MHT described herein) in the invention.
  • a known SAM-dependent methyhalide transferase such as a MHT described herein
  • percentage of sequence identity means the value determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences.
  • the percentage is calculated by determining the number of positions at which the identical amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison, and multiplying the result by 100 to yield the percentage of sequence identity.
  • methyl halide production In addition to introduction and manipulation of MHT genes, other genetic modifications can be made to increase the efficiency of methyl halide production, or increase the amount of methyl halide produced. These changes include increasing the intracellular concentration of reaction substrates such as halides and S-adenosylmethionine (also called “SAM” or “AdoMet”). Intracellular levels of SAM can be increased by changing the rate of SAM biosynthesis (e.g., by raising levels of SAM precursors), reducing SAM consumption, and the like. Intracellular levels of halide can be increased by stimulating transport of halides into the cell, adding halides to the extracellular environment, and the like. In general, techniques of metabolic engineering can be used to maximize production of methyl halides.
  • Methyl halide production can be increased by manipulating flux though metabolic pathways that affect SAM levels, such as SAM biosynthetic pathways, methionine biosynthetic pathways, SAM utilization or degradation pathways, and SAM recycling pathways.
  • SAM biosynthetic pathways such as SAM biosynthetic pathways, methionine biosynthetic pathways, SAM utilization or degradation pathways, and SAM recycling pathways.
  • S-adenosylmethionine is a ubiquitous metabolite involved in multiple metabolic pathways that entail methyl transfer.
  • One such pathway is indicated below:
  • SAM is synthesized from ATP and methionine, a reaction catalyzed by the enzyme S-adenosylmethionine synthetase (SAM synthetase, EC 2.5.1.6; Cantano, 1953, J. Biol. Chem. 1953, 204:403-16.
  • SAM synthetase EC 2.5.1.6; Cantano, 1953, J. Biol. Chem. 1953, 204:403-16.
  • a MHT-expressing cell is modified to increase SAM synthase activity by overexpression of endogenous SAM synthetase or introduction of a heterologous SAM synthase.
  • SAM synthetase (SAMS) genes include metK in prokaryotes such as E. Coli (Acc. No. NP — 289514.1), and sam1p (Acc.
  • SAMS can be overexpressed in a cell by introducing a heterologous SAMS gene or introducing additional copies of the SAMS genes of the host organisms, under the control of a constitutive or inducible promoter.
  • Yu et al., 2003, Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao ( Shanghai ) 35:127-32 described enhanced production of SAM by overexpression in Pichia pastoris of an S. cerevisiae SAM synthetase 2 gene.
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs, orthologs and variants with the same enzymatic activity.
  • methyl halide transferase catalyses conversion of SAM to S-adenosyl-homocysteine.
  • S-adenosyl-homocysteine is “recycled” back to SAM via SAM biosynthetic pathways.
  • SAM production or levels can thus be increased by increasing the level and/or activity of enzymes in the pathways.
  • enzymes include SAM-dependent methylase (EC 2.1.1), methionine synthase (EC 2.1.1.13 or EC 2.1.1.14), and N 5 -methyl-tetrahydropteroyltriglutamate-homocysteine methyltransferase (e.g., yeast METE).
  • SAH1 S-adenosyl-L-homocysteine hydrolase
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • SAM utilization pathways Various metabolic pathways within the methyl halide producing organisms cause a decrease in intracellular levels of free SAM (SAM utilization pathways).
  • SAM utilization pathways The content and/or the biological activity of one or more enzymes involved in a SAM utilization pathway can be decreased in order to facilitate or increase methyl halide production.
  • genes that can be inhibited to reduce SAM utilization include S-adenosylmethionine decarboxylase (corresponding to E. coli gene speD). Further examples include cystathionine beta-synthetase, ribulose 5-phosphate 3-epimerase, glucose-6-phosphate dehydrogenase, L-alanine transaminase, 3′,5′-bisphosphate nucleotidase, glycine hydroxymethyl transferase (reversible, mitochondrial), glycine hydroxymethyl transferase (reversible), corresponding to S. cerevisae genes CYS4, Rpe1, Zwf1, Alt, Met22, Shm 1-m, and Shm 2.
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • a SAM transport protein involved in the transport of SAM into a cell from the extracellular environment is expressed or over expressed in a cell.
  • Examples include the Sam5p protein from yeast and homologs such as GenBank ID Nos. BC037142 ( Mus musculus ), AL355930 ( Neurospora crassa ), AE003753 ( Drosophila melanogaster ), Z68160 ( Caenorhabditis elegans ) and SLC25A26 (human). See Marrobio et al., 2003, EMBO J. 22:5975-82; and Agrimi et al., 2004, Biochem. J. 379:183-90.
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • SAM biosynthesis and in turn methyl halide production, can be increased by the use of microorganisms with increased efficiency for methionine synthesis.
  • the basic metabolic pathways leading to methionine synthesis are well known (see, e.g. Voet and Voet, 1995, Biochemistry, 2nd edition, Jon Wiley &Sons, Inc.; Ruckert et al., 2003, J. of Biotechnology 104, 2 13-228; and Lee et al., 2003, Appl. Microbiol. Biotechnol., 62:459-67).
  • These pathways are generally under strict regulation by various mechanisms such as feedback control. (See, e.g., Neidhardt, 1996, E. coli and S. typhimurium , ASM Press Washington). Accordingly, the expression or repression of relevant genes, or increase in the levels and/or activity of the corresponding gene products), can result in increased methionine production.
  • Genes that can be expressed or upregulated include those involved in methionine biosynthesis.
  • PCT Publication WO 02/10209 incorporated by reference in its entirety, describes the over-expression or repression of certain genes in order to increase the amount of methionine produced.
  • methionine biosynthetic enzymes include O-acetyl-homoserine sulfhydrylase (metY) and O-succinyl-homoserine sulfhydrylase (metZ).
  • genes include methylene tetrahydrofolate reductase (MetF); aspartate kinase (lysC); homoserine dehydrogenase (horn); homoserine acetyltransferase (metX); homoserine succinyltransferase (metA); cystathionine ⁇ -synthetase (metB); cystathionine ⁇ -lyase (metC); Vitamin B 12 -dependent methionine synthase (metH); Vitamin B 12 -independent methionine synthase (metE); N 5,10 -methylene-tetrahydrofolate reductase (metF) and S-adenosylmethionine synthase (metK).
  • MetalF methylene tetrahydrofolate reductase
  • lysC aspartate kinase
  • metalX homoserine acetyltransferase
  • methyl halide production can be increased in prokaryotes such as E. Coli and Corynebacterium by overexpressing genes such as metY, metA, metB, metC, metE, and/or metH, or otherwise increasing the levels or activity of their gene products.
  • repressor proteins genes can increase methyl halide production (e.g., repressor encoded by the metJ or metD (McbR) genes, which repress methionine synthesis-related genes such as metB, metL and metF).
  • McbR metD
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • Methionine synthesis can also be increased by modifying the flux through those pathways that provide additional precursors, examples of which include sulfur atoms in different oxidative states, nitrogen in the reduced state such as ammonia, carbon precursors including Cl-carbon sources such as serine, glycine and formate, precursors of methionine, and metabolites of tetrathydrofolate substituted with carbon at N5 and or N10.
  • additional precursors examples of which include sulfur atoms in different oxidative states, nitrogen in the reduced state such as ammonia, carbon precursors including Cl-carbon sources such as serine, glycine and formate, precursors of methionine, and metabolites of tetrathydrofolate substituted with carbon at N5 and or N10.
  • energy e.g. in the form of reduction equivalents such as NADH, NADPH or FADH2 can be involved in the pathways leading to methionine.
  • methyl halide production can be increased by increasing the level and/or activity of gene products involved in sulfate assimilation, cysteine biosynthesis and conversion of oxaloacetate to aspartate semialdehyde.
  • genes include L-cysteine synthase (cysK), NADPH-dependent sulphite reductase (cysl) and alkane sulfonate monooxygenase (ssuD).
  • Enzymes involved in serine synthesis include D-3-phosphoglycerate dehydrogenase (SerA), phosphoserine phosphatase (SerB) and phosphoserine aminotransferase (SerC). See WO 07/135,188, incorporated by reference in its entirety. Enzymes involved in serine synthesis can be modified to reduce or prevent feedback inhibition by serine.
  • genes include serine hydroxymethyltransferase (SHMT) and methylene tetrahydrofolate reductase (metF).
  • SHMT serine hydroxymethyltransferase
  • metalF methylene tetrahydrofolate reductase
  • the content and/or the biological activity of one or more enzymes involved in serine degradation to pyruvate e.g., serine dehydratase, sdaA
  • serine export from the cell e.g., ThrE
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • Genes controlling methionine uptake in a cell can be modified to increase methyl halide production.
  • the MetD locus in E. Coli encodes an ATPase (metN), methionine permease (men) and substrate binding protein (metQ). Expression of these genes is regulated by L-methionine and MetJ, a common repressor of the methionine regulon.
  • Orthologs are known in many other species such as Salmonella, Yersinia, Vibrio, Haemophilus, Agrobacterium, Rhizobium and Brucella . See, e.g., Merlin et al., 2002, J. Bacteriology 184:5513-17. et al., 2003, EMBO J. 22:5975-82; and Agrimi et al., 2004, Biochem. J. 379:183-90.
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • Methyl halide production can also be increased by increasing the intracellular halide concentration in MHT-expressing cells. This can be accomplished in various ways, e.g., by introducing or increasing the levels and/or activity of one or more halide transporters, and/or increasing halide concentration in the medium. Examples include Gef1 of Saccharomyces cerevisiae , EriC of E. coli (P37019), and Synechocystis (P74477).
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • Methyl halide production can also be increased by methyl halide synthesis activity is increased by increasing the intracellular concentration and/or availability of ATP.
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • the activity and/or level of methyl halide utilizing enzymes can be decreased. These include enzymes in the cmu gene cluster such as cmuC, cmuA, orf146, paaE and hutI. Other enzymes include bacterial 10-formyl-H 4 folate hydrolases, 5,10-methylene-H 4 folate reductase and purU and corrinoid enzymes such as halomethane: bisulfide/halide ion methyltransferase.
  • gene names vary from organism to organism and reference above to a gene name is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • the invention provides a recombinant yeast cell comprising a heterologous gene encoding S-adenosylmethionine (SAM)-dependent methyl halide transferase (MHT).
  • SAM S-adenosylmethionine
  • MHT MHT-dependent methyl halide transferase
  • MHT proteins that can be expressed in yeast include, as discussed elsewhere herein, those from Batis maritima, Burkholderia phymatum, Synechococcus elongatus, Brassica rapa, Brassica oleracea, Arabidopsis thaliana, Arabidopsis thaliana, Leptospirillum, Cryptococcus neoformans, Oryza sativa, Ostreococcus tauri, Dechloromonas aromatica, Coprinopsis cinerea, Robiginitalea bofirmata, Maricaulis maris, Flavobacteria bacterium, Vitis vinifera or halorhodospira halophila .
  • yeast cells examples include, as discussed elsewhere herein, Saccharomyces cerevisiae, Pichia pastoris, Hansenula polymorpha, Kluyveromyces lactis, Yarrowia lipolytica, Trichoderma reesei, Scizosacchromyces pombe , and others. Methods for culture and genetic manipulation of yeast are well known in the art.
  • methyl halide transferase e.g., Batis maritima MCT
  • Saccharomyces cerevisiae results in the production of methyl halide (e.g., methyl iodide).
  • the yield is increased significantly by using a peptide signal to target the enzyme to vacuoles. See discussion below. Without intending to be limited to a particular mechanism, the increased production is believed to result from (i) the sequestration of the majority of the cell's SAM in the vacuole (Farooqui et al., 1983, Studies on compartmentation of S-adenosyl-L-methionine in Saccharomyces cerevisiae and isolated rat hepatocytes.
  • One peptide signal is the N-terminal peptide domain from carboxypeptidase Y known to target pendant proteins to the yeast vacuole, but other targeting peptides may be used. See, e.g., Valls et al., 1990, Yeast carboxypeptidase Y vacuolar targeting signal is defined by four propeptide amino acids. J Cell Biol 111:361-8; and Tague et al., 1987, “The Plant Vacuolar Protein, Phytohemagglutinin, Is Transported to the Vacuole of Transgenic Yeast”, J.
  • the coding sequence of B. maritima methylchloride transferase is synthesized and cloned into a high copy vector under the control of a tet-repressible CYC promoter (plasmid pCM190, Gari et al, 1997, Yeast 13:837-48).
  • the MCT coding sequence is fused to a N-terminal peptide domain from carboxypeptidase Y known to target pendant proteins to the yeast vacuole (amino acid sequence: KAISLQRPLGLDKDVL, Valls et al., 1990, J. Cell Biol. 111:361-8.) This expression system is transformed into S.
  • Yeast carrying MCT expression vectors are streaked on uracil dropout plates from freezer stocks (15% glycerol) and grown for 48 hours. Individual colonies are inoculated into 2 mL of synthetic complete uracil dropout media and grown overnight at 30 degrees. Cultures are next inoculated into 100 mL fresh synthetic complete uracil dropout media and grown for 24 hours. Cells are spun down and concentrated to high cell density (OD 50) in fresh YP media with 2% glucose and 100 mM sodium iodide salt. 10 mL of this concentrated culture is aliquoted into 14 mL culture tubes and sealed with a rubber stopper.
  • the GC-MS system consists of a model 6850 Series II Network GC system (Agilent) and model 5973 Network mass selective system (Agilent). Oven temperature is programmed from 50 degrees (1 min) to 60 degrees (10 degrees/min). 100 microliters of culture headspace is withdrawn through the rubber stopper with a syringe and manually injected into the GC-MS and methyl iodide production measured.
  • the targeting of other enzymes involved in metabolic processes to the vacuole can be used to increase production.
  • yield from reactions in which a substrate(s) is SAM and/or a halide can be increased by such targeting.
  • ethylene may be produced by a metabolic pathway using SAM (see, e.g., U.S. Pat. No. 5,416,250, incorporated herein by reference).
  • a yeast e.g., S.
  • ACC 1-aminocyclopropane-1 carboxylic acid
  • ACC 1-aminocyclopropane-1 carboxylic acid
  • EFE ethylene forming enzyme
  • the process of the invention makes use of cells selected or modified at multiple (e.g., at least 2, sometimes at least 3, sometimes at least 4, and sometimes 5 or more than 5) different loci to increase methyl halide production.
  • Cells may have additional genetic modifications to facilitate their growth on specific feedstocks, to provide antibiotic resistance and the like.
  • strains developed for different purposes may be further modified to meet the needs of the current invention.
  • the strain carries a deregulated horn gene to abolish feedback inhibition of homoserine dehydrogenase by threonine and a deletion of the thrB gene to abolish threonine synthesis.
  • modified strains can be obtained by selection processes instead of recombinant technology, where organisms can be mutagenized and screened for methionine overproduction.
  • High-producing strains have been isolated in many organisms including E. coli and yeast. See, e.g., Alvarez-Jacobs et al., 2005, Biotechnology Letters, 12:425-30; Dunyak et al., 1985, 21:182-85; Nakamori et al., 1999, Applied Microbiology and Biotechnology 52:179-85.
  • gene names vary from organism to organism and reference above to a gene name above is not intended to be limiting, but is intended to encompass homologs with equivalent activity.
  • the encoded protein need not be identical to the naturally occurring version, so long as the overexpressed protein has the appropriate activity and can be expressed in the host.
  • the invention includes the use of enzymatically active polypeptides with at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or at least 99% identity with a known protein described hereinabove.
  • Genetic modification can be achieved by genetic engineering techniques or using classical microbiological techniques, such as chemical or UV mutagenesis and subsequent selection.
  • a combination of recombinant modification and classical selection techniques may be used to produce the organism of interest.
  • nucleic acid molecules can be introduced, deleted, inhibited or modified, in a manner that results in increased yields of methyl halide within the organism or in the culture.
  • Methods for genetic manipulation of procaryotes and eukaryotes are very well known in the art. Accordingly, methods are only very briefly described.
  • genes that contribute to methyl halide production, and/or the presence, levels, and/or activity of the corresponding gene products can be achieved or increased.
  • Overexpression can be accomplished by introducing a recombinant construct that directs expression of a gene product in a host cell, or by altering basal levels of expression of an endogenous gene product, for example by inducing or de-repressing its transcription, or enhancing the transport, stability and/or activity of gene products such as mRNA and/or protein. Codon optimization of non-endogenous nucleic acid sequences can also increase translation efficiency.
  • Stable introduction of cloned genes can be accomplished for example by maintaining the cloned gene(s) on replicating vectors or by integrating the cloned gene(s) into the genome of the production organism. Examples include multi-copy plasmids, transposons, viral vectors or YACs.
  • the vector can contain an origin of replication such as PSC101, BAC, p15a or ColE1 (in prokaryotes) or ARS (yeast) or the SV40 origin (eukaryotes).
  • Expression vectors that can be used to produce a desired protein can comprise an operable linkage of (1) DNA elements coding for an origin for the maintenance of the expression vector in a host cell; (2) DNA elements that control initiation of transcription, such as a promoter; (3) DNA elements that control the processing of transcripts, such as a transcriptional terminator, and (4) optionally, a gene encoding a selectable marker, such as antibiotic resistance.
  • the sequence to be expressed can be placed under the control of a promoter that is functional in the desired prokaryotic or eukaryotic organism.
  • a promoter that is functional in the desired prokaryotic or eukaryotic organism.
  • An extremely wide variety of promoters are well known, and can be used, depending on the particular application.
  • Inducible and constitutive promoters are both encompassed by the invention.
  • Inducible promoters include those induced by arabinose (PBAD); IPTG (PTRC), halide salts (e.g., sodium chloride), osmolarity, sugar, starch, cellulose, or light.
  • methyl halide production using an IPTG-inducible promoter in bacteria increases to peak levels within 1-2.5 hours after induction of expression.
  • genes can be increased by operatively linking the gene(s) to native or heterologous transcriptional control elements. This can be done by the use of synthetic operons, ribosome binding sites, transcription termination sites and the like.
  • Various prokaryotic and eukaryotic expression control sequences are known in the art. See, e.g., WO 06/069220, incorporated by reference in its entirety.
  • An example of a sequence encoding a recombinant ribosome binding site is ATTAAAGAGGAGAA ATTAAGC.
  • Recombinant sequences can be optimized for protein expression in a particular host species by changing any codons within a cloned gene that are not preferred by the organism's translation system to preferred codons without changing the amino acid sequence of the synthesized protein. Codon optimization can increase the translation of a recombinant gene.
  • the DNA sequence of a gene can be varied so as to maximize the difference with the wild-type DNA sequence, for example to avoid the possibility of regulation of the gene by the host cell's regulatory proteins.
  • genes that tend to limit, regulate or decrease methyl halide production, or the presence, levels, and/or activity of the corresponding gene products (mRNA and/or protein), can be abolished or decreased.
  • Genetic modifications that result in a decrease in expression and/or function of the gene and/or gene product can be through complete or partial inactivation, suppression, deletion, interruption, blockage or down-regulation of a gene. This can be accomplished for example by gene “knockout,” inactivation, mutation, deletion, or antisense technology.
  • Gene knockout can be accomplished using art-known methods including commercially available kits such as the “TargeTron gene knockout system” (Sigma-Aldrich).
  • E. coli strains with individual gene knockouts can be obtained from the E. coli genome project (www.genome.wisc.edu).
  • the invention includes multiple knockouts, e.g., 2-6 genes in same organism.
  • the invention also includes any combination of gene introductions, deletions or modifications.
  • the terms “cultivation” and “fermentation” are used interchangeably herein to refer to the culture of MHT-expressing cells in liquid media under conditions (either aerobic or anaerobic) in which methyl halides are produced.
  • the growth medium used for production of methyl halides will depend largely on the host organism. Suitable growth conditions many procaryotes and eukaryotes commonly used in the laboratory or industrial settings are known and described in the scientific literature. See, e.g., Ball, A. S., 1997, B ACTERIAL C ELL C ULTURE : E SSENTIAL D ATA John Wiley & Sons; Richmond, A., 2003, H ANDBOOK OF M ICROALGAL C ULTURE Wiley-Blackwell; Becker, E.
  • a nutrient or cultivation media will include a carbon source, a halide source, as well as nutrients.
  • the medium should also contain appropriate amounts of nitrogen and sulfur sources, e.g., in the form of one or more sulfates (such as ammonium sulfate) and/or thiosulfates.
  • the medium can also contain vitamins such as vitamin B12.
  • One suitable medium for bacteria such as E. coli is Luria-Bertani (LB) broth.
  • Carbon-containing substrates are metabolized to supply the methyl portion of methyl halides. Carbon compounds can also be metabolized to provide energy to drive methyl halide production.
  • Substrates include carbon-containing compounds such as petroleum and/or natural gas, carbohydrates, in which carbon is present in a form that can be metabolized by the organism of choice. Examples of carbohydrates include monosaccharides, sugars such as glucose, fructose, or sucrose, oligosaccharides, polysaccharides such as starch or cellulose, and one-carbon substrates or mixtures thereof, for example presented in the form of feedstock. Carbon dioxide can also be used as a carbon source, especially when photosynthetic organisms such as algae are used.
  • Common carbon-containing raw materials that can be used include but are not limited to wood chips, vegetables, biomass, excreta, animal wastes, oat, wheat, corn (e.g., corn stover), barley, milo, millet, rice, rye, sorghum, potato, sugar beets, taro, cassaya, fruits, fruit juices, and sugar cane.
  • Particularly useful are switchgrass ( Panicum virgatum ), elephant grass ( Miscanthus giganteus ), bagasse, poplar, corn stover and other dedicated energy crops.
  • the optimal choice of substrate will vary according to choice of organism. As noted above, when cellulosic materials are used as carbon sources, organisms such as Erwinia, E.
  • E. coli and Saccharomyces are examples of organisms that can be used to metabolize starches and sugarcane.
  • photosynthetic organisms such as algae (e.g., Chlorella and Prototheca ) can metabolize carbon sources such as CO 2 .
  • algae e.g., Chlorella and Prototheca
  • cellulosic stocks may be blended or pulverized before addition to culture.
  • methyl halide production can be increased by optimizing the composition of the growth medium.
  • the yield of methyl halides can also be increased by increasing the intracellular concentration of one or more reactants or precursors such as halides, methionine, SAM, and intermediates in SAM biosynthesis.
  • Use of media rich in methionine, serine, and/or halide can increase methyl halide production.
  • the concentration of methionine in the medium is from about 0.5 gm/L to about 10 gm/L.
  • concentration of serine in the medium is from about 0.5 gm/L to about 10 gm/L.
  • halide salts include chlorides, iodides or bromides of sodium, potassium, magnesium, and the like.
  • methyl halide production increases with atomic weight of the halide.
  • iodides can give better yield than bromides which in turn tend to given better yield than chlorides.
  • methyl halide production can be increased by adjusting the concentration of halides in the medium.
  • the optimal osmolarity of a medium is often about 0.01 to 1 M, often about 0.05 to 0.3, such as about 0.1 M.
  • the optimal concentration of a chosen halide salt can be determined empirically by one of skill guided by this disclosure.
  • the invention contemplates the use of NaCl at about 0.01 to 0.1 M, often about 0.05 to 0.5 M, for example about 0.1 M, such as 0.085 M.
  • Media such as Luria-Bertani (LB) broth (0.171 M of NaCl) are suitable.
  • LB broth can also be prepared with various counter-ions made up to about 0.16 M.
  • an LB broth preparation of 5 g/L yeast extract, 10 g/L tryptone and 0.5 g/L NaCl can be supplemented with 16.7 g/L NaBr or 24.4 g/L NaI.
  • Increasing the levels of serine for example by providing a serine-rich nutrient source can also result in increased methionine production. See, e.g., WO 07/135,188, incorporated by reference in its entirety).
  • the organisms can be maintained or cultivated under conditions that are conducive for methyl halide production. Many parameters such as headspace ratio, growth phase and oxygen levels can affect methyl halide production.
  • the invention contemplates culture conditions in which the organisms are in stationary phase or exponential (log) phase. Stationary phase is often suited for methyl halide production. Similarly, the invention also encompasses both aerobic and anaerobic growth of cultures. On occasion, aerobic growth is appropriate. Cell density can sometimes be increased (and nutrient concentrations can be also increased correspondingly) without impairing methyl halide production. Some host cells are maintained at elevated temperature (e.g., 37° C.) with agitation. In one approach, solid state fermentation is used (see, Mitchell et al., S OLID -S TATE F ERMENTATION B IOREACTORS, 2006, Springer). Aerobic or anaerobic conditions may be selected, depending in part on the organism and strain.
  • the ratio of headspace gas (air) per liquid culture volume can be optimized according to the invention using Henry's law. It has been determined that the optimum ratio is generally about 0.5:1 to 4:1, for example about 2:1.
  • Methyl halides and non-halogenated organic molecules produced using methods of the invention are usually produced at an industrial scale, for example for production of biofuels suitable as petroleum substitutes. Accordingly, organisms comprising a S-adenosylmethionine (SAM)-dependent methyl halide transferase (MHT) may in some embodiments be cultivated in bioreactors having a liquid capacity of at least 10 liters, at least 50 liters, at least 100 liters, or at least 500 liters. Often a bioreactor with a liquid capacity of at least 1000 liters, at least 5,000 liters, or at least 10,000 liters, for example.
  • SAM S-adenosylmethionine
  • MHT methyl halide transferase
  • the volume of cultivation medium in cultures of the invention is at least 10 liters, at least 25 liters, at least 50 liters, at least 100 liters, at least 500 liters, at least 1,000 liters, or at least 5,000 liters.
  • Culture may be carried out as a batch fermentation, in a continuous culture bioreactor, or using other methods known in the art.
  • the invention provides a method for production of any of a variety of biological or organic products using cellulosic feedstocks as the sole or primary carbon source.
  • a co-culture comprising a mesophyllic cellulolytic bacterium (e.g., Actinotalea fermentans ) and a recombinant yeast (e.g., S. cerevisiae ) is prepared.
  • Cellulose e.g., cellulose, microcrystalline cellulose, Avicel, a cellulosic feedstock
  • hemicellulose and/or lignin may be used in addition to or in place of cellulose in certain embodiments.
  • raw or partially processed cellulosic feedstock is used.
  • the cellulose is then metabolized by the bacterium to produce products which serve as a carbon source for the yeast.
  • the recombinant yeast is thus able to carry out metabolic processes in a co-culture fed with cellulose.
  • the bacteria-yeast co-culture is maintained under aerobic conditions. In some embodiments the bacteria-yeast co-culture is maintained under anaerobic conditions.
  • the co-culture is a symbiotic co-culture.
  • a symbiotic co-culture is one in which the yeast is dependent on the bacterium for carbon (i.e., in the form of compounds that are waste products of bacteria metabolism), and the bacterium is dependent on the yeast for metabolism of toxic waste products. That is, the accumulation of bacterial waste products, in the absence of the yeast symbiant inhibits growth or viability of the bacteria.
  • a cellulolytic bacterium that (a) metabolizes cellulose to produce ethanol and (b) is subject to growth inhibition by ethanol may be used in a symbiotic co-culture with a yeast that metabolizes ethanol.
  • a cellulolytic bacterium that (a) metabolizes cellulose to produce acetate and (b) is subject to growth inhibition by acetate may be used in a symbiotic co-culture with a yeast that metabolizes acetate.
  • a cellulolytic bacterium that (a) metabolizes cellulose to produce lactate and (b) is subject to growth inhibition by lactate may be used in a symbiotic co-culture with a yeast that metabolizes lactate.
  • dependent does not necessarily imply absolute dependency, but may mean that growth or viability of the organism is higher or more stable in co-culture.
  • a symbiotic bacteria-yeast co-culture can be described as a mutually obligatory cooperative system, in which each organism is dependent upon the other for viability.
  • cellulolytic bacteria are suitable for use in co-culture.
  • the cellulolytic bacterium is a cellulomonas or actinotalea species.
  • exemplary celluolytic bacteria include Trichoderma harzianum, Trichoderma reesei, Cellulomonas uda, Cellulomonas flavigena, Cellulomonas cellulolyticum, Pseudomonas species and Thermomonospora species.
  • Bacteria capable of aerobic fermentation of cellulose to ethanol, acetate, or lactate are well suited for co-culture. Also well suited for co-culture are bacteria capable of aerobic fermentation of cellulose to succinate, citrate, formate or malate. In some embodiments bacteria capable of anaerobic fermentation of cellulose to ethanol, acetate, lactate succinate, citrate, formate or malate are used. Cellulosic bacteria may be recombinantly modified (e.g., to incorporate drug resistance markers, modify a synthetic pathway in the cell, etc.).
  • cellulolytic bacteria are selected based on growth inhibition by the product of the bacterial metabolism of cellulose (e.g., growth inhibition by ethanol, acetate, lactate succinate, citrate, formate or malate). It will be appreciated that bacteria exhibiting such growth inhibition are particularly useful for symbiotic co-cultures. Cellulolytic bacteria exhibiting such growth inhibition may be identified by reference to the scientific literature or may be identified or selected in the laboratory. In some embodiments, recombinant techniques are used to render a particular type or stain of bacterial susceptible to such inhibition.
  • bacteria is not a Lactobacillus species. In some embodiments the bacteria is not Lactobacillus kefuranofaciens.
  • the bacterium is Actinotalea fermnentans.
  • A. fermentans is available from the American Type Culture Collection (ATCC 43279) and was previously referred to as Cellulomonas fermentans (see Yi et al., 2007, “Demequina aestuarii gen. nov., sp. nov., a novel actinomycete of the suborder Micrococcineae, and reclassification of Cellulomonas fermentans Bagnara et al. 1985 as Actinotalea fermentans gen. nov., comb.
  • yeast strains and species may be used.
  • the yeast is S. cerevisiae (e.g., S. cerevisiae W303a).
  • another yeast species is used (e.g., Pichia pastoris, Hansenula polymorpha, Kluyveromyces lactis, Yarrowia lipolytica, Sacharomyces , and Scizosacchromyces pombe ).
  • the co-culture may comprise any combination of cellulolytic bacteria and yeast so long as the products of bacterial metabolism of cellulose can be used as a energy and carbon source by the yeast.
  • the metabolism of cellulose by the bacterium produces secreted acetate and/or ethanol.
  • Other end products of cellulosic bacteria include secreted lactate, succinate, citrate, malate, formate and other organic molecules (typically having 1-6 carbon atoms).
  • the cellulosic bacterium is A. fermnentans and the yeast is S. cerevisiae.
  • the yeast is recombinantly engineered to produce a product of interest.
  • S. cerevisiae may be modified to express Batis Maritima MHT.
  • Co-cultures with yeast engineered to express MHT may be used to produce may be methylhalide, as described in the examples.
  • co-culture may be applied in many other applications. That is, given any yeast recombinantly modified to produce a product of interest, the product may be produced using a co-culture of the yeast and cellulosic bacterium in the presence of a cellulose source and any substrates required by the yeast to produce the product.
  • the yeast product may be a drug, food product, amino acid, cofactor, hormone, proteins, vitamin, lipid, industrial enzyme or the like.
  • Examples of products produced by recombinant yeast include small molecule drugs (see, e.g., Ro et al., 2006 “Production of the antimalarial drug precursor artemisinic acid in engineered yeast” Nature 440(7086):940-3; petrochemical building blocks (see, e.g., Pirkov et al., 2008, “Ethylene production by metabolic engineering of the yeast Saccharomyces cerevisiae” Metab Eng. 10(5):276-80; commercially or medically useful proteins (see, e.g., Gerngross et al., 2004, “Advances in the production of human therapeutic proteins in yeasts and filamentous fungi” Nat Biotechnol; 22(11):1409-14).
  • Exemplary medically useful proteins include insulin, hepatitis B antigen, desirudin, lepidurin, and glucagon.
  • hepatitis B antigen for other examples see Porro et al., 2005, “Recombinant protein production in yeasts” Mol Biotechnol. 31(3):245-59.
  • Still others include 3 Glycerol, 3 hydroxypropionic acid, lactic acid, malonic acid, propionic acid, Serine; 4 Acetoin, aspartic acid, fumaric acid, 3-hydroxybutyrolactone, malic acid, succinic acid, threonine; 5 Arabinitol, furfural, glutamic acid, itaconic acid, levulinic acid, proline, xylitol, xylonic acid; Aconitic acid, citric acid, and 2,5 furan dicarboxylic acid.
  • the invention includes the further step of collecting or harvesting the product of interest produced by the yeast cells.
  • the product of interest is a small molecule compound with a molecular weight less than 1000.
  • the bacteria and yeast components of the co-culture are grown together (comingled) in the liquid cultivation medium.
  • the co-cultured organisms can be, for example, maintained in separate compartments of a bioreactor, separated by a permeable membrane that allows metabolites and other molecules to diffuse between compartments.
  • suitable bioreactors are known in the art.
  • cultivation or growth media for use in coculture will include appropriate amounts of nitrogen and sulfur sources, e.g., in the form of one or more sulfates (such as ammonium sulfate) and/or thiosulfates.
  • the medium can also contain vitamins such as vitamin B12.
  • YP media may be used (Bacto-yeast extract (Difco) 10 gram, Bacto-peptone (Difco) 20 gram, ddH2O to 900 ml). Methods of optimizing cultivation conditions may be determined using art known techniques. See, e.g., Ball, A.
  • the invention provides a bacteria-yeast co-culture in which the bacteria metabolizes cellulose and produce one or more metabolic products, and the yeast uses the metabolic products of the bacterium as a carbon source.
  • the microorganisms adapted to grow together while maintaining a relatively constant ratio of species populations such that neither microorganism overtakes the other.
  • bacteria-yeast co-cultures of the type described below in Section 5.1 we typically observed 100-fold excess of bacteria over yeast (approximately 1 million viable yeast cells and 100 million viable bacterial cells per milliliter).
  • Methyl iodide production in yeast offers several advantages over existing building block molecules, including compatibility with industrial processes.
  • the production of biofuels and bio-based building blocks from food crop derived sugars may directly contribute to global food shortages.
  • methyl iodide (and other bio-based molecules) must be derived from cellulosic feedstocks, which include “energy crops” such as switchgrass ( Panicum virgatum ) and elephant grass ( Miscanthus giganteus ) as well as agricultural wastes such as corn stover.
  • energy crops such as switchgrass ( Panicum virgatum ) and elephant grass ( Miscanthus giganteus )
  • agricultural wastes such as corn stover.
  • the conversion of these real-world biomass sources to fermentable sugars and products is problematic due to the recalcitrance of lignocellulosic materials to microbial digestion.
  • A. fermentans ferments cellulose to acetate and ethanol aerobically, which S. cerevisiae are able to utilize as a carbon source.
  • A. fermentans growth is inhibited by accumulation of acetate and ethanol, creating a metabolic interdependence in the community, with S. cerevisiae dependent on A. fermentans for carbon, and A. fermentans dependent on S. cerevisiae for metabolism of toxic waste products ( FIG. 9A ).
  • FIG. 9A We inoculated S. cerevisiae with A.
  • CFU colony forming units
  • Yeast grown in co-culture for 36 hours increase to 10 6 cfu/ml, where yeast without the cellulolytic partner show little growth ( FIG. 9B , left panel).
  • the presence of yeast also increases the growth rate of the bacterium by consuming toxic components ( FIG. 9B , right panel). This interaction demonstrates a symbiotic relationship.
  • Energy crops such as switchgrass offer several advantages over conventional crops by requiring fewer agricultural inputs and by growing on marginal land, or by exhibiting extraordinary growth or genetic tractability (e.g., poplar).
  • Agricultural residues such as corn ( Zea mays ) stover are another source of cellulosic carbon, with approximately 200 mg of stover produced in the United States each year. The results show that methyl iodide can be produced from a variety of cellulosic carbon sources.
  • the invention provides a method for production of methyhalide comprising culturing a first microorganism which metabolizes cellulose and produces one or more metabolic products together with a second microorganism which does not metabolize cellulose and which is recombinantly modified to express a heterologous methyl halide transferase protein in a medium containing cellulose and a halide (e.g., chlorine, bromine and iodine) under conditions in which methyl halide is produced.
  • a halide e.g., chlorine, bromine and iodine
  • Methyl halides are volatile and escape into the vapor above the liquid culture. On a production scale this is advantageous over, for example, other biofuel intermediates because relatively little extra energy is required for purification of methyl halides, if so desired.
  • the methyl halide can be collected before conversion to one or more non-halogenated organic molecules.
  • the collection step is omitted, for example when the same organisms that produce methyl halide also convert the methyl halide to organic molecules.
  • Cultivation, collection of methyl halide, and/or conversion of methyl halide to organic compounds such as higher-molecular weight compounds (below) can be carried out in a reactor system.
  • Methods for chemical processing and bioreactor systems are known in the art and can be readily adapted to the present invention.
  • Volatile methyl halide can be collected by any known method from the fermenter by transferring methyl halide that is produced in gaseous form to a condenser.
  • the temperature of the gas comprising methyl halide can be lowered, for example resulting in the liquefaction of methyl halides but not other gaseous components, allowing for easy purification.
  • Catalytic condensation or other reactions can take place in a reactor.
  • Halide salts, generated as a by-product of the condensation reaction, can be recycled, e.g., by introducing back into the fermenter.
  • Gas phase production can be easily measured by, for example by gas chromatography mass spectroscopy, which determines the number of methyl halide molecules produced.
  • the total amount of methyl halides produced can be calculated using Henry's Law.
  • the methyl halides can be converted to organic products such as alcohols, alkanes, (ethane-octane or longer), ethers, aldehydes, alkenes, olefins, and silicone polymers. These products in turn can be used to make a very wide range of petrochemical products, sometimes referred to as “biofuels.”
  • alkyl halides, including methyl halides, in the production of more complex organic compounds is known in the conventional petrochemical industry.
  • Conversion can be achieved by a variety of known methods, including biological conversion (e.g., through the use of biological organisms that can convert the methyl halide into non-halogenated organic molecules, for example through the action of one or more enzymes). If so desired, the conversion can be carried out in the same reactor or vessel in which the organism(s) that produce methyl halide are maintained. The conversion can be carried out by the same organisms that produce methyl halide or by different organisms, present within the same reactor or segregated in a different compartment or reactor. An organism can be modified to produce or convert (or both produce and convert) methyl halide to a greater rate or extent than an unmodified organism. When conversion is achieved by the same organisms that produce methyl halide, the collection of methyl halide can optionally be omitted. Both production and conversion can optionally be carried out in the same vessel or reactor.
  • biological conversion e.g., through the use of biological organisms that can convert the methyl halide into non-halogenated organic molecules, for
  • the methyl halides can be converted to various organic molecules by the use of chemical catalysts. Depending on the choice of substrates (chemical catalyst used and/or methyl halide) as well as adjustment of different variables such as temperature, (partial) pressure and catalyst pre-treatment, various organic products can be obtained. For example, the use of a metal oxide catalyst can result in the production of higher alkanes. The use of an AlBr 3 catalyst can result in the production of propane. If the desired product is an alcohol, an ether or an aldehyde, the methyl halide can be passed over a specific metal oxide that is selected based upon its selectivity to produce the desired functionality (i.e. alcohol, ether or aldehyde). Should the desired product selectivity be affected by the amount of water present in the reaction between the alkyl monohalide and the metal oxide, water can be added to the alkyl monobromide feed to the appropriate level.
  • zeolites include naturally-occurring zeolites such as Amicite, Analcime, Barrerite, Bellbergite, Bikitaite, Boggsite, Brewsterite, Chabazite, Clinoptilolite, Cowlesite, Vietnamese ardite, Edingtonite, Epistilbite, Erionite, Faujasite, Ferrierite, Garronite, Gismondine, Gmelinite, Gobbinsite, Gonnardite, goosecreekite, Harmotome, Herschelite, Heulandite, Laumontite, Levyne, Maricopaite, Mazzite, Merlinoite, Mesolite, Montesommaite, Mordenite, Natrolite, Offretite, Paranatrolite, Paulingite, Pentasil, Perlialite, Phillipsite, Pollucite, Scolecite, Sodium Dachiardite
  • Synthetic zeolites can also be used.
  • the use of zeolites to generate from methyl halides are well known in the art. See, e.g., Svelle et al., 2006, Journal of Catalysis, 241:243-54, and Millar et al., 1995, U.S. Pat. No. 5,397,560, both incorporated by reference in its entirety, discussing the use of a zeolite to produce hydrocarbon-type products, including alkenes such as ethene, propene and butenes, as well as ethylbenzenes and higher aromatics.
  • the methyl halide have various other uses, for example as a solvent in the manufacture of butyl rubber and in petroleum refining, as a methylating and/or halidating agent in organic chemistry, as an extractant for greases, oils and resins, as a propellant and blowing agent in polystyrene foam production, as a local anesthetic, as an intermediate in drug manufacturing, as a catalyst carrier in low temperature polymerization, as a fluid for thermometric and thermostatic equipment and as a herbicide.
  • Batis Maritima MHT cDNA (Genbank Acc. No. AF109128 or AF084829) was artificially synthesized and cloned into an expression vector pTRC99a.
  • E. coli -MHT Batis The resulting E. coli (strain DH10B) comprising the expression construct encoding Batis maritima MHT under the control of an IPTG inducible promoter is referred to as the “ E. coli -MHT Batis ” strain.
  • Methyl halide production can be measured by gas chromatography.
  • GC/MS gas chromatography/mass spectrometry
  • AIR.U ionization voltage of 1341. In some experiments an ionization voltage of about 1250 was used.
  • a solvent delay of 0 was set and the scan parameters set to 15-100 MW.
  • the injection port and column were preset to 50° C.
  • the sample to be tested was mixed by shaking for a few seconds. 100 ⁇ L of the headspace gas was extracted with a gas-tight syringe. The sample gas was manually injected into the GCMS injection port.
  • the GCMS program was started with the following settings: 1:00 at 50° C.; a ramp of 10° C. per min to 70° C. (the sample typically came off at ⁇ 52° C.); 1:00 at 70° C.
  • the column was then cleaned (ramp to 240° C. for 2 minutes).
  • the sample peak was identified by extracting the GC peak corresponding to 50 MW ( ⁇ 0.3, +0.7). This peak was integrated to produce the “GC 50 MW” data.
  • E. coli strains DH10B, BL21, or MC1061
  • Salmonella SL 1344
  • a plasmid encoding a codon-optimized methyl chloride transferase gene MCT from Batis maritima as described in Example 1.
  • 10 mL of LB media with 1 mM IPTG was inoculated with a single colony of plated cells in a 16 mL culture tube. The tube was then sealed with parafilm and aluminum foil cinched with a rubber band. The cultures were incubated at 37° C. while shaking for 4-22 hours and methyl halide production measured. Each of the strains produced methylchloride.
  • E. coli strain DH10B transformed with a plasmid encoding a codon-optimized methyl chloride transferase gene MCT from Batis maritima as described in Example 1 was incubated in the presence of inducer (IPTG). As shown in FIG. 1 , increasing IPTG levels resulted in increased methylchloride production
  • methyl halide production increased linearly with time in the inducing media up to about 1 to 2.5 hours after induction.
  • Methyl halide production was compared between aerobic and anaerobic culture conditions. Aerobic conditions resulted in higher levels of methyl halide cultures.
  • E. coli -MHT Batis cells were grown in modified Luria-Bertani (LB) media in which the NaCl concentration was varied.
  • Normal LB medium contains 5 g/L yeast extract, 10 g/L Tryptone, 10 g/L NaCl (0.171 M NaCl), at pH 7.
  • Methyl chloride production in LB and modified LB containing 0.85 or 0.017 M NaCl was tested. Results are summarized in FIG. 4 . 0.085 M NaCl produced the best results. However, normal LB was near optimal.
  • a standardized assay was devised. 20 mL of LB was inoculated with a single colony of plated cells, and was incubated at 37° C. while shaking for about 10-14 hours. The cells were pelleted and resuspended in LB. Equal aliquots were added to 10 mL LB, LB-Br or LB-I media with IPTG and incubated for 1.5 hours. 100 ⁇ L of headspace gas was taken and the amounts of methyl halide present measured as in Example 2.
  • the higher molecular weight halides had higher methyl halide yield, with iodine ion giving the greatest yield, followed by bromine ion and chlorine ion.
  • the production rate of methyl iodide was calculated to be about 40 (specifically, 43) mg/L per day.
  • the effect on methyl halide production by over-expression of certain accessory proteins was tested.
  • the E. coli -MHT Batis strain was transformed with plasmids encoding E. coli metK, E. coli clcA, or E. coli vqb genes. Cells were cultured and methyl chloride production was measured. As shown in FIG. 6 , overexpression of metK improved yield of methyl chloride. Under the conditions used, the expression of vgb and clcA caused general toxicity.
  • methyl halide transferase genes from various organisms were codon-optimized and introduced into E. Coli . Production of methyl bromide and methyl iodide was determined for each. As shown in Table 5, the genes were from Batis maritime, Burkholderia phymatum STM815, Synechococcus elongatus PCC 6301, Brassica rapa subsp. chinensis; Brassica oleracea TM1, Brassica oleracea TM2; Arabidopsis thaliana TM1; Arabidopsis thaliana TM2; Leptospirillum sp. Group II UBA; Cryptococcus neoformans var.
  • the MHT sequences are shown in Table 4. Table 5 shows the level of amino acid identity with the Batis maritima protein.
  • neoformans 33 JEC21 OS Oryza sativa ( japonica cultivar-group) 58 OT Ostreococcus tauri 33 DA Dechloromonas aromatica RCB 30 CC Coprinopsis cinerea okayama 36 RB Robiginitalea bofirmata HTCC2501 32 MM Maricaulis maris MCS10 30 AT-2 Arabidopsis thaliana TM2 67 FB Flavobacteria bacterium BBFL7 28 VV Vitis vinifera 59 HH Halorhodospira halophila SL1 28
  • a single colony was picked and grown overnight (10-14 hrs) in 20 mL of LB miller in a 30 mL glass test tube with aeration (a loose cap) at 37 C and 250 rpm shaking.
  • the culture was spun down in a swinging bucket centrifuge for 5 min @ 3000 ⁇ g.
  • the cells were resuspended in 20 mL of appropriate media (10 g/L Tryptone, 5 g/L Yeast Extract, 165 mM NaX [where X ⁇ Cl, Br, I]) containing 100 uM IPTG inducer.
  • the cells were sealed with rubber stoppers and parafilm and grown at 37 C with 250 rpm shaking for 1.5 hours.
  • Methyl halide production was measured as described in the previous Examples. The results are summarized in FIG. 7 .
  • the B. maritima transferase was found to give the best methyl bromide production, while the B. phymatum transferase gave the best methyl bromide production in bacteria.
  • C. neoformans JEC21 gave the best methyl bromide and methyl iodide production.
  • Leptospirillum gave the best methyl iodide production.
  • Enzymes from O. sativa, O. tauri; D. aromatica , and C. cinerea showed significant specificity for methyl iodide production.
  • B. maritima, Brassica rapa subsp. chinensis and B. oleracea show significant specificity for methyl bromide production.
  • the enzymes RB, MM, AT-2, FB, VV and HH in Table 5 showed insignificant activity.
  • Proteins with MHT activity were identified through a BLAST protein-protein search for proteins having sequence identity with known MHTs such as from the MHT from Batis maritima . A cutoff of ⁇ 28% identity was assigned based on a 29% identity between Batis maritima and Burkholderia phymatum MHT sequences. Each identified sequence was BLASTed back to the database and a new list was generated. This was repeated until no additional sequences were found. Table 6 sets forth the sequences (and corresponding GenBank accession numbers) that have been identified as having MHT activity, including proteins that were hitherto not recognized to have MHT activity. Many of the newly identified proteins are thiopurine s-methyltransferases.
  • Codon-optimized nucleic acids encoding the sequences above are synthesized and inserted into expression vectors active in E. coli, S. cervisiae , and other host cells.
  • the cells are cultured in the presence of carbon and halide sources and under conditions in which the methylhalide transferase is expressed un under conditions in which methyl halide is produced.
  • the methyl halide is optionally collected and converted into non-halogenated organic molecules.
  • Example 9A to screen for MHTs with high activity in a recombinant host, we synthesized all putative MHTs from the NCBI sequence database and assayed methyl halide production in E. coli .
  • the library contains a remarkable degree of sequence diversity, with an average of 26% amino acid identity between sequences.
  • the library includes putative, hypothetical, and misannotated genes, as well as genes from uncharacterized organisms and environmental samples. These genes were computationally codon optimized for E. coli and yeast expression and constructed using automated whole gene DNA synthesis. This is an example of information-based cloning, where genetic data was retrieved from databases, the genes chemically synthesized, and function assayed, without contact with the source organisms.
  • Methyl halide activity was assayed on three ions (chloride, bromide, and iodide) by adding the appropriate halide salt to the growth media. Methyl halide production was sampled by analyzing the headspace gas using GC-MS (Supplementary Information). We found a wide distribution of activities on each ion, with 51% of genes showing activity on chloride, 85% of genes showing activity on bromide, and 69% of genes showing activity on iodide ( FIG. 10A ). In particular, the MHT from Balls maritima, a halophytic plant, displayed the highest activity of all genes on each ion. Several genes showed unique specificities for given ions ( FIG.
  • B. maritima MHT gene was transferred to the yeast Saccharomyces cerevisia ( FIG. 11A ).
  • One advantage to metabolic engineering in a eukaryotic host is the ability to target gene products to specific cellular compartments that may be more favorable environments for enzyme function.
  • maritima MHT to the yeast vacuole could increase methyl iodide yield: the majority of SAM is sequestered in the vacuole (Farooqui et al., 1983, “Studies on compartmentation of S-adenosyl-L-methionine in Saccharomyces cerevisiae and isolated rat hepatocytes,” Biochim Biophys Acta 757:342-51) and halide ions are sequestered there as well (Wada and Anraku, 1994 “Chemiosmotic coupling of ion transport in the yeast vacuole: its role in acidification inside organelles,” J Bioenerg Biomembr 26: 631-7).
  • Yeast displayed high production rate from glucose or sucrose ( FIGS. 11B and 11C ) and normal growth rates. Methyl iodide yield from glucose was measured at 4.5 g/L-day, which is 10-fold higher than that obtained from E. coli and approximately 12,000-fold over the best natural source ( FIG. 11C ). In addition to rate, the carbon conversion efficiency of glucose to methyl iodide is an important parameter in determining process viability. For yeast, we determined the maximum theoretical yield of methyl iodide as 0.66 (mole fraction) from the balanced equation:
  • the maximum efficiency of carbon liberation from glucose is identical to the maximum efficiency of ethanol from glucose.
  • the measured carbon conversion efficiency of glucose to methyl iodide is 2.5%, indicating room for yield improvement by redirecting carbon flux to SAM.
  • Methyl halides are S N 2 methylating agents known to cause cytotoxic lesions in ssDNA and RNA.
  • yeast were resistant to deleterious methylating effects of methyl iodide up to high levels (>5 g/L, FIG. 11D ). Because the fermentation is aerobic and methyl iodide has a large Henry's constant (see Moore et al., 1995, Chemosphere 30:1183-91), it can be recovered from the off-gas of the fermentor.
  • a mutant strain deficient in a DNA-repair gene (RAD50 ⁇ Symington et al., 2002, Microbiol Mol Biol Rev 66:630-70) showed increased sensitivity to methyl iodide, confirming the role of methylation stress in cellular toxicity.
  • Cloning was performed using standard procedures in E. coli TOP10 cells (Invitrogen). Primers are listed below.
  • the MHT coding regions were synthesized by DNA 2.0 (Menlo Park, Calif.) in the pTRC99a inducible expression vector carrying a gene for chloramphenicol resistance. Constructs were transformed into DH10B strain for methyl halide production assays. For yeast expression, the B. maritima MHT coding region was cloned into vector pCM190.
  • Cloning was performed using standard procedures in E. coli TOP10 cells (Invitrogen).
  • the B. maritima MCT coding region was synthesized by DNA 2.0 (Menlo Park, Calif.) and amplified using specified primers with PfuUltra II (Stratagene) according to manufacturer's instructions.
  • PCR products were purified using a Zymo Gel Extraction kit according to manufacturer's instructions.
  • Purified expression vector (pCM190) and coding region insert were digested with restriction enzymes NotI and PstI overnight at 37 degrees and gel purified on a 1% agarose gel and extracted using a Promega Wizard SV Gel kit according to manufacturer's instructions.
  • Vector and insert were quantitated and ligated (10 fmol vector to 30 fmol insert) with T4 ligase (Invitrogen) for 15 minutes at room temperature and transformed into chemically competent E. coli TOP10 cells (Invitrogen). Transformants were screened and plasmids were sequenced using specified primers to confirm cloning.
  • Constructs were transformed into the S. cerevisiae W303a background using standard lithium acetate technique and plated on selective media. Briefly, competent W303a cells were prepared by sequential washes with water and 100 mM lithium acetate in Tris-EDTA buffer. 1 ⁇ g of plasmid was incubated for 30 minutes at 30 degrees with 50 ⁇ L of competent cells along with 300 ⁇ L of PEG 4000 and 5 ⁇ g of boiled salmon sperm DNA as a carrier. Cells were then heat-shocked at 42 degrees for 20 minutes. Cells were spun down and resuspended in 100 ⁇ L water and plated on synthetic complete uracil dropout plates. Plates were incubated at 30 degrees for 48 hours and positive transformants were confirmed by streaking on uracil dropout plates.
  • Bacteria carrying MHT expression vectors were inoculated from freshly streaked plates and grown overnight. Cells were diluted 100-fold into media containing 1 mM IPTG and 100 mM appropriate sodium halide salt. Culture tubes were sealed with a rubber stopper and grown at 37 degrees for 3 hours. Yeast carrying MHT expression vectors were streaked on uracil dropout plates from freezer stocks (15% glycerol) and grown for 48 hours. Individual colonies were inoculated into 2 mL of synthetic complete uracil dropout media and grown overnight at 30 degrees. Cultures were next inoculated into 100 mL fresh synthetic complete uracil dropout media and grown for 24 hours.
  • Cells were spun down and concentrated to high cell density (OD 50) in fresh YP media with 2% glucose and 100 mM sodium iodide salt. 10 mL of this concentrated culture was aliquoted into 14 mL culture tubes and sealed with a rubber stopper. Cultures were grown at 30 degrees with 250 rpm shaking.
  • the GC-MS system consisted of a model 6850 Series II Network GC system (Agilent) and model 5973 Network mass selective system (Agilent). Oven temperature was programmed from 50 degrees (1 min) to 70 degrees (10 degrees/min). 100 ⁇ L of culture headspace was withdrawn through the rubber stopper with a syringe and manually injected into the GC-MS. Samples were confirmed as methyl iodide by comparison with commercially obtained methyl iodide (Sigma), which had a retention time of 1.50 minutes and molecular weight of 142. Methyl iodide production was compared to a standard curve of commercially available methyl iodide in YPD.
  • Standards were prepared at 0.1 g/L, 0.5 g/L 1.0 g/L, and 10 g/L in 10 mL YP media plus 2% glucose, aliquoted into 14 mL culture tubes and sealed with rubber stoppers. Standards were incubated at 30 degrees for 1 hour and methyl iodide in the headspace was measured as above. A standard curve was fit to the data to relate headspace counts with methyl iodide.
  • Efficiency was measured as grams of high energy carbon produced per grams of glucose consumed. Methyl iodide production was measured by GC-MS of the culture headspace and the fraction of methyl iodide in the liquid phase was calculated using a standard curve. Grams of high energy carbon (—CH 3 ) are calculated by subtracting the molecular weight of the halide ion to give a comparison with other hydrocarbon production technologies. Amount of glucose consumed was calculated by measuring glucose in the growth media before and after a defined amount of time (90 min) with a hexokinase kit (Sigma) as per manufacturer's instructions and was quantitated using a standard glucose curve.
  • methyl iodide production was measured by inducing cultures as above, assaying methyl iodide at 1 hour, and venting the culture to simulate product extraction. Cultures were then re-sealed and methyl iodide was measured again to determine how much methyl iodide had been vented. Cultures were again grown for 1 hour, measured, and vented. Data is displayed in the main text by summing the production each hour.
  • Actinotalea fermentans was obtained from ATCC (43279).
  • A. fermentans and S. cerevisiae cells were inoculated in either YP media+2% glucose (for S. cerevisiae ) or BH media+2% glucose (for A. fermentans ) and grown overnight.
  • Corn stover and poplar were pulverized using a commercially available blender with a 1 HP, 1000 W motor. Bagasse was aliquoted into the appropriate dry weight, then washed 3 times with hot water to remove soil and residual sugar. Cultures were incubated at 30 degrees with 250 rpm agitation for 36 hours.
  • S. cerevisiae and A. fermentans were quantitated from cultures grown on cellulosic stocks by plating on selective media. Cultures were diluted in sterile water and 100 uL was plated on either YPD agar+ampicillin (to quantitate S. cerevisiae ) or brain-heart agar (to quantitate A. fermentans ). Plates were incubated at 30 degrees for either 48 hours (for YPD) or 16 hours (for BH). Colonies were counted by hand and counts from at least 4 plates were averaged. In the switchgrass and corn stover grown cultures some unidentified background cultures were apparent but showed distinguishable morphology from A. fermentans.
  • A. fermentans (ATCC 43279)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
US12/745,538 2007-11-30 2008-11-26 Industrial production of organic compounds using recombinant organisms expressing methyl halide transferase Abandoned US20110151534A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/745,538 US20110151534A1 (en) 2007-11-30 2008-11-26 Industrial production of organic compounds using recombinant organisms expressing methyl halide transferase

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US99167807P 2007-11-30 2007-11-30
US3836808P 2008-03-20 2008-03-20
US4146708P 2008-04-01 2008-04-01
US9822108P 2008-09-18 2008-09-18
US12/745,538 US20110151534A1 (en) 2007-11-30 2008-11-26 Industrial production of organic compounds using recombinant organisms expressing methyl halide transferase
PCT/US2008/085019 WO2009073560A1 (fr) 2007-11-30 2008-11-26 Production industrielle de composés organiques à l'aide d'organismes recombinants exprimant un halogénure transférase de méthyle

Publications (1)

Publication Number Publication Date
US20110151534A1 true US20110151534A1 (en) 2011-06-23

Family

ID=40718114

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/745,539 Active 2031-07-28 US9657279B2 (en) 2007-11-30 2008-11-26 Biological systems for production of commercially valuable compounds
US12/745,538 Abandoned US20110151534A1 (en) 2007-11-30 2008-11-26 Industrial production of organic compounds using recombinant organisms expressing methyl halide transferase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/745,539 Active 2031-07-28 US9657279B2 (en) 2007-11-30 2008-11-26 Biological systems for production of commercially valuable compounds

Country Status (8)

Country Link
US (2) US9657279B2 (fr)
EP (2) EP2222833A4 (fr)
JP (2) JP2011505148A (fr)
CN (2) CN101932699A (fr)
AU (2) AU2008334087A1 (fr)
BR (2) BRPI0819648A2 (fr)
CA (2) CA2706894A1 (fr)
WO (2) WO2009073560A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160347682A1 (en) * 2015-05-26 2016-12-01 Sabic Global Technologies, B.V. Zeolite Catalyst for Alkyl Halide to Olefin Conversion

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2222833A4 (fr) 2007-11-30 2011-05-18 Univ California Production industrielle de composés organiques à l'aide d'organismes recombinants exprimant un halogénure transférase de méthyle
WO2011011627A1 (fr) * 2009-07-22 2011-01-27 The Regents Of The University Of California Systèmes à base de cellules pour la production de formiate de méthyle
WO2011088364A2 (fr) * 2010-01-15 2011-07-21 Massachuseits Institute Of Technology Bioprocédé et ingéniérie microbienne pour une utilisation totale du carbone dans la production d'un biocarburant
JP5051485B2 (ja) 2010-02-25 2012-10-17 富山県 出芽酵母を用いたグルクロン酸抱合体の製造方法
CN102766586B (zh) * 2011-05-12 2013-05-15 江南大学 中国酱香型白酒生产中高产乙醇低产杂醇油的酵母cgmcc 4747的筛选与应用
AT511856A1 (de) * 2011-09-01 2013-03-15 Univ Graz Tech Mittel und verfahren zur alkylierung
EP2871234A1 (fr) * 2013-11-06 2015-05-13 Leibniz-Institut für Pflanzenbiochemie (IPB) Variantes de la synthase de S-adénosylméthionine (SAM) pour la synthèse de cofacteurs artificiels
WO2016181216A1 (fr) * 2015-05-08 2016-11-17 Universidad Adolfo Ibanez Compositions de pgpr et procédés pour améliorer la culture d'espèces de tomates et de pommes de terre
CN106994134B (zh) * 2016-01-25 2020-08-25 深圳华大生命科学研究院 肠道益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
MX2019002835A (es) 2016-09-13 2019-09-04 Allergan Inc Composiciones no proteínicas de toxina clostridial.
CN109306333B (zh) * 2018-10-25 2020-06-12 北京润世能源技术有限公司 一株微生物采油菌w-y8及其应用
CN109536426B (zh) * 2019-01-25 2021-11-16 黑龙江大学 一株嗜冷菌及其应用
KR20240009458A (ko) 2021-05-17 2024-01-22 아쿠아컬쳐드 푸즈 인크 박테리아와 균류의 공동 배양물을 포함하는 식품

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510243A (en) * 1981-10-14 1985-04-09 The Agency Of Industrial Science And Technology Anaerobic digestion process of wastes containing cellulose
US5514586A (en) * 1989-10-25 1996-05-07 Nestec S.A. Plasmid vectors and GRAS microorganisms promoting ice nucleation
US5643758A (en) * 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US6610504B1 (en) * 2000-04-10 2003-08-26 General Atomics Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
US6649397B1 (en) * 1998-05-06 2003-11-18 Orient Green Co., Ltd. Microbial culture liquors containing microorganisms differing in characteristics and living in symbiosis and metabolites thereof, carriers and adsorbents containing the active components of the culture liquors and utilization of the same
US20040175805A1 (en) * 2003-03-06 2004-09-09 Consortium Fur Electrochemische Industrie Gmbh Method for fermentative preparation of S-adenosylmethionine
US20040265953A1 (en) * 2000-08-11 2004-12-30 Harman Gary E. Production and use of inducible enzymes from trichoderma and bacteria for control of plant pests and for industrial processes
US20050267023A1 (en) * 2002-08-09 2005-12-01 Sinclair David A Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US20060235088A1 (en) * 2005-04-15 2006-10-19 Olah George A Selective oxidative conversion of methane to methanol, dimethyl ether and derived products
US7160704B2 (en) * 2003-03-04 2007-01-09 Ajinomoto Co., Inc. Method for producing target substance
US20070026505A1 (en) * 2005-06-17 2007-02-01 Madden Kevin T Amino acid and metabolite biosynthesis
US20070118916A1 (en) * 2005-10-14 2007-05-24 Metanomics Gmbh Process for the production of fine chemicals
US20070178569A1 (en) * 2006-01-27 2007-08-02 Susan Leschine Systems and methods for producing biofuels and related materials

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794080A (en) * 1984-04-16 1988-12-27 Igene Biotechnology, Inc. Microbial co-culture production of propionic acid
US7109005B2 (en) * 1990-01-15 2006-09-19 Danisco Sweeteners Oy Process for the simultaneous production of xylitol and ethanol
EP0684308B2 (fr) * 1994-05-27 2004-01-14 Agrano Ag Procédé d'obtention d'une biomasse et ferment de panification
EP0684307B1 (fr) * 1994-05-27 1999-12-15 Agrano Ag Procédé de préparation de milieux de culture utilisables pour la culture individuelle de levures et de bactéries lactiques ou la coculture de levures et de bactéries lactiques.
PT1023435E (pt) * 1997-10-17 2007-01-31 Nestle Sa Nova espécie de bactéria láctica
CN1649808A (zh) * 2001-05-23 2005-08-03 陶氏环球技术公司 从单碳原料的卤乙烯生产
US20030152586A1 (en) * 2002-01-25 2003-08-14 Biomedis Dietary supplements comprising growth media
EP2222833A4 (fr) 2007-11-30 2011-05-18 Univ California Production industrielle de composés organiques à l'aide d'organismes recombinants exprimant un halogénure transférase de méthyle

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510243A (en) * 1981-10-14 1985-04-09 The Agency Of Industrial Science And Technology Anaerobic digestion process of wastes containing cellulose
US5643758A (en) * 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US5514586A (en) * 1989-10-25 1996-05-07 Nestec S.A. Plasmid vectors and GRAS microorganisms promoting ice nucleation
US6649397B1 (en) * 1998-05-06 2003-11-18 Orient Green Co., Ltd. Microbial culture liquors containing microorganisms differing in characteristics and living in symbiosis and metabolites thereof, carriers and adsorbents containing the active components of the culture liquors and utilization of the same
US6610504B1 (en) * 2000-04-10 2003-08-26 General Atomics Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
US20040265953A1 (en) * 2000-08-11 2004-12-30 Harman Gary E. Production and use of inducible enzymes from trichoderma and bacteria for control of plant pests and for industrial processes
US20050267023A1 (en) * 2002-08-09 2005-12-01 Sinclair David A Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US7160704B2 (en) * 2003-03-04 2007-01-09 Ajinomoto Co., Inc. Method for producing target substance
US20040175805A1 (en) * 2003-03-06 2004-09-09 Consortium Fur Electrochemische Industrie Gmbh Method for fermentative preparation of S-adenosylmethionine
US20060235088A1 (en) * 2005-04-15 2006-10-19 Olah George A Selective oxidative conversion of methane to methanol, dimethyl ether and derived products
US20070026505A1 (en) * 2005-06-17 2007-02-01 Madden Kevin T Amino acid and metabolite biosynthesis
US20070118916A1 (en) * 2005-10-14 2007-05-24 Metanomics Gmbh Process for the production of fine chemicals
US20070178569A1 (en) * 2006-01-27 2007-08-02 Susan Leschine Systems and methods for producing biofuels and related materials

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Eksteen et al. Biotechnol Bioeng. 2003 Dec 20;84(6):639-46. *
Ni et al. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3611-5. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160347682A1 (en) * 2015-05-26 2016-12-01 Sabic Global Technologies, B.V. Zeolite Catalyst for Alkyl Halide to Olefin Conversion

Also Published As

Publication number Publication date
AU2008334090A1 (en) 2009-06-11
JP2011505148A (ja) 2011-02-24
JP2011505149A (ja) 2011-02-24
CN101932699A (zh) 2010-12-29
US20110165618A1 (en) 2011-07-07
WO2009073557A2 (fr) 2009-06-11
EP2238239A4 (fr) 2011-07-06
CA2706894A1 (fr) 2009-06-11
CN101932694A (zh) 2010-12-29
CA2707446A1 (fr) 2009-06-11
AU2008334087A1 (en) 2009-06-11
US9657279B2 (en) 2017-05-23
EP2222833A1 (fr) 2010-09-01
BRPI0819648A2 (pt) 2017-05-23
BRPI0819649A2 (pt) 2017-01-10
EP2222833A4 (fr) 2011-05-18
WO2009073560A1 (fr) 2009-06-11
EP2238239A2 (fr) 2010-10-13
WO2009073557A3 (fr) 2009-12-30

Similar Documents

Publication Publication Date Title
US9040266B2 (en) Cell-based systems for production of methyl formate
US9657279B2 (en) Biological systems for production of commercially valuable compounds
US11624057B2 (en) Glycerol free ethanol production
JP2019103519A (ja) 合成ガスまたは他のガス状炭素源およびメタノールを利用するための方法および生物体
CN106536742B (zh) D-赤藓糖和乙酰磷酸的酶促生产方法
CN107002019B (zh) 产生3-羟基丙酸的重组酵母和使用其产生3-羟基丙酸的方法
WO2010057022A1 (fr) Micro-organismes pour la production de méthyléthylcétone et de 2-butanol
US20160289708A1 (en) Methods and compositions for production of acetaldehyde
EP2909325A1 (fr) Micro-organismes et procédés d'amélioration de la disponibilité d'équivalents réducteurs en présence de méthanol, et de production de succinate correspondant
Xia et al. GroE chaperonins assisted functional expression of bacterial enzymes in Saccharomyces cerevisiae
WO2014207113A1 (fr) Levures techniquement conçues pour la production de substances chimiques de valeur à partir de sucres
WO2019110492A1 (fr) Cellule de levure recombinante
WO2014207087A1 (fr) Production de carburants avancés et de produits chimiques par des levures selon le concept de biocarburants de deuxième génération
WO2014207099A1 (fr) Production biologique anoxique de carburants et de produits chimiques en vrac à partir de matières premières de deuxième génération
Deng et al. Driving carbon flux through exogenous butyryl-CoA: acetate CoA-transferase to produce butyric acid at high titer in Thermobifida fusca
WO2013115959A1 (fr) Procédés et compositions de croissance de levure sur un alginate
EP4320253A1 (fr) Synthèse de bêta-hydroxyisovalérate et méthodes d'utilisation
ES2607894T3 (es) Enzimas productoras de acetil-CoA en levadura
Sullivan Engineering a fungal L-arabinose pathway towards the co-utilization of hemicellulosic sugars for production of xylitol
Sommer Fakultät für Chemie Fachgebiet Industrielle Biokatalyse
Sommer A new synthetic biology methodology for the cell-free production of industrial alcohols
Hitschler et al. Aurora Pathway

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, CALIF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VOIGT, CHRISTOPHER;BAYER, TRAVIS S.;SIGNING DATES FROM 20100420 TO 20100528;REEL/FRAME:025495/0825

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION